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SUMMARY
As an important component of transcriptome, long noncoding RNA (lncRNA) refers to
noncoding RNA whose length is above 200 nt. lncRNAs play important biological roles,
such as dosage compensation, genomic imprinting, cell differentiation and have been im-
plicated in human disease. Although some lncRNAs have been characterized, the functions
of most lncRNAs currently remain unclear. To characterize lncRNAs, identifying lncRNAs
and inferring their functions is necessary. In this dissertation, we propose a novel lncRNA
identification and functional annotation tool named LncADeep.
lncRNA identification refers to distinguishing lncRNAs from mRNAs. As a preva-
lent method for studying lncRNAs, current RNA-seq techniques tend to generate short
reads, impeding accurate full-length transcript assembly. Thus, lncRNA identification is
further complicated by partial-length mRNAs reconstructed from RNA-seq short reads,
since partial-length mRNAs truncated at 5’ and/or 3’ end can lead to incomplete coding se-
quences (CDS), which are prone to be misclassified as lncRNAs. However, most tools focus
on identifying lncRNAs from full-length transcripts, and it is necessary to develop a method
for lncRNA identification from transcripts including full- and partial-length. Herein, we
propose LncADeep, which identifies lncRNAs by integrating sequence intrinsic and ho-
mology features based on deep belief networks. In particular, LncADeep constructs two
models for lncRNA identification, one targeting full-length transcripts and the other target-
ing transcripts including full- and partial-length. Benchmarked with eleven state-of-the-
art lncRNA identification tools (i.e., CPC, CPC2, CPAT, CNCI, COME, lncRScan-SVM,
lncRNA-MFDL, longdist, lncScore, FEElnc and PLEK) with 10-fold cross-validation, our
tool LncADeep has outperformed them on full-length human transcripts with an accu-
racy of 97.7% (sensitivity 98.1%, specificity 97.2%), and transcripts including full- and
partial-length with an accuracy of 94.2% (sensitivity 93.8%, specificity 94.5%). Besides,
LncADeep still outperformed the above tools on cross-species lncRNA identification on
xv
full-length mouse transcripts with an accuracy of 96.7% (sensitivity 97.0%, specificity
96.3%) and transcripts including full- and partial-length with an accuracy of 94.2% (sensi-
tivity 95.1%, specificity 93.3%). Results have shown that LncADeep is a robust lncRNA
identification tool, which outperforms state-of-the-art tools on full-length transcripts, tran-
scripts including full- and partial-length, and cross-species lncRNA identification.
Since lncRNA-protein interactions play the crucial roles in the functioning of lncR-
NAs, we propose to infer the functions through predicting lncRNA-protein interactions.
Herein, LncADeep predicts lncRNA-protein interactions using sequence and structure fea-
tures based on deep neural networks, where LncADeep has achieved a higher accuracy of
90.8% (sensitivity 97.0%, specificity 85.4%) than state-of-the-art tools including lncPro,
RPISeq, RPI-pred, rpiCool, and IPMiner. To infer the functions of lncRNAs, LncADeep
conducts KEGG and Reactome pathway enrichment analysis and functional module de-
tection with the predicted interacting proteins of lncRNAs. Compared with the above
five tools, not only can LncADeep predict lncRNA-protein interaction with better per-
formance, but also provide functional annotations for lncRNAs automatically. We then
annotate the 27,384 lncRNAs collected by GENCODE database, and LncADeep annotated
each lncRNA with with an average of 25 KEGG and 67 Reactome pathways. In contrast,
using IPMiner’s predicted proteins for enrichment analysis, we only obtained an average
of 5 KEGG and 28 Reactome pathways for each lncRNA, which is less than LncADeep’s
annotation. Moreover, case studies show that LncADeep’s functional annotations for lncR-
NAs comply with their known functions.
In summary, we develop a novel lncRNA identification and functional annotational tool,
LncADeep (http://cqb.pku.edu.cn/ZhuLab/LncADeep), based on deep learning algorithms.
First, LncADeep outperformed state-of-the-art lncRNA identification tools on full-length
transcripts and transcripts including full- and partial-length. Since transcripts reconstructed
from RNA-seq dataset are composed of full- and partial-length, LncADeep is particularly
useful for RNA-seq community. Second, LncADeep outperformed state-of-the-art tools
xvi
on predicting lncRNA-protein interactions. Based on the predicted lncRNA-protein in-
teractions, LncADeep provides rich functional annotations, conforming with the known
functions, for lncRNAs. To our knowledge, LncADeep is the first tool which can identify
lncRNA and annotate lncRNAs functions automatically. Currently, there are still a large
amount of lncRNAs to be identified, while the functions of most lncRNAs remain unclear.
We expect that not only can LncADeep contribute to identifying lncRNAs, but also provide
helpful functional information for investigating the associations among lncRNAs, gene reg-
ulation and diseases, and then facilitate the large-scale automatic genome annotation.
CHAPTER 1
INTRODUCTION
This chapter intends to introduce the motivation and background for this dissertation, which
is mainly about LncADeep: an ab initio long noncoding RNA (lncRNA) identification and
functional annotation tool based on deep learning methods. lncRNA is a critical compo-
nent of transcriptome, playing important biological roles and attracts much attention. As
an approach to studying transcriptome and with the development of high-throughput se-
quencing technologies, RNA sequencing (RNA-seq) has clear advantages over some other
approaches such as microarray, and has become the preferred method. To characterize
lncRNAs from RNA-seq data, lncRNA identification and functional annotation is neces-
sary. Herein, we first give a introduction to RNA-seq, and then introduce the background
of lncRNA. As we use deep learning methods for lncRNA identification and functional an-
notation, we then give a brief description for neural networks and deep learning methods.
1.1 RNA-seq for studying transcriptomics
The term transcriptome was originally proposed by Charles Auffray in 1996, and defined
as the entire sets of transcripts [1]. As a intermediate of the flow of the genetic information,
transcriptome consists of various categories of transcripts, such as protein-coding RNAs
(or mRNAs), noncoding RNAs and small RNAs. One key aim of transcriptomics is to
catalogue these categories of transcripts and investigate their transcriptional structures, such
as alternative splicing patterns, 5’ and 3’ ends [2, 3]. In addition, another important aim of
transcriptomics is to quantify the transcript expression under various conditions, which can
help to, for example, reveal the differentially expressed transcripts among tissues, between
sexes, etc [4, 3]. Characterizing transcriptome can not only help to “interpret the functional
elements of the genome and reveal the molecular constituents of cells and tissues”, but also
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“understand development and disease” [3].
1.1.1 Technologies for studying transcriptomics
To characterize transcriptome, several technologies have been developed. The early tech-
nologies are low-throughput, such as Serial/Cap Analysis of Gene Expression (SAGE/CAGE)
[5, 6], which are based on the expressed sequence tags (ESTs) using low-throughput Sanger
sequencing technologies. However, these low-throughput technologies have largely been
overtaken by high-throughput technologies like microarray and RNA sequencing (RNA-
seq), which are dominant technologies for characterizing transcriptome and can provide
more helpful information.
Microarray is composed of fixed probes (such as short oligonucleotides or cDNA) ar-
rayed on a solid substrate (such as glass slide), to which the fluorescently labelled tran-
scripts can bind and then generate fluorescence signals [7, 8]. After hybridisation and
washes, the abundance of transcripts can be determined by the total strength of fluorescence
signals at each probe location. However, to synthesize the probes, microarray requires prior
knowledge, such as a reference genome or transcriptome, limiting its application on new
organisms whose reference genome or transcriptome is not available.
Unlike microarray which highly depends on prior knowledge, RNA-seq can directly
determine the sequence using high-throughput sequencing technologies, such as Illumina
[9]. A typical RNA-seq experiment [10] is illustrated in Figure 1.1. First, after being
isolated from tissues, transcripts are converted to RNA fragments. Second, RNA frag-
ments are reverse-transcribed to complementary DNAs (cDNAs). Third, cDNAs are used
for library preparation, including ligating adapters and PCR amplification. Finally, with
high-throughput sequencing, the resulting short sequence reads can be used for quantifying
expression level with data analysis.
Compared with microarray, RNA-seq has several advantages. (i) Resolution: The res-
olution of RNA-seq is single base, which is particular helpful for discovering single nu-
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cleotide variants, while that of microarray ranges from several to 100 nt [11]. (ii) Back-
ground noise: The observed intensity of each probe in microarray is mixed up with spe-
cific and nonspecific binding, and optical noise, which requires complicated methods for
background noise adjustment [12], while RNA-seq does not suffer this problem. (iii) De-
tecting highly and lowly expressed genes: The dynamic range of detecting gene expression
level of RNA-seq is almost unlimited, while that of microarray is limited to a few hundred
[13]. Therefore, because of these clear advantages over microarray, RNA-seq has become
















Figure 1.1: The flowchart of a typical RNA-seq experiment.
1.1.2 RNA-seq data analysis
To mining meaningful information from RNA-seq data, the data analysis is necessary. A
typical RNA-seq data analysis pipeline includes four steps, (i) sequence alignment and
assembly, (ii) expression quantification, (iii) expression normalization, and (iv) differential
expression analysis.
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Sequence alignment refers to aligning the short reads to a reference genome or tran-
scriptome, which is usually available for model organisms. Aligning short reads to the
reference genome can help to discover novel transcripts which have not been annotated.
However, because of the splice junctions of exons in eukaryotic genome, it is necessary to
use spliced aligners. There are many spliced aligners, such as Tophat2 [14], STAR [15],
MapSplice [16], HISAT [17], GEM [18] and PASSION [19], which can detect novel splice
junctions. If novel transcripts are not interested, aligning reads to a reference transcrip-
tome using un-spliced aligners will suffice. There are also several un-spliced aligners, such
as Bowtie2 [20], BWA [21], WHAM [22]. Regardless of spliced or un-spliced aligners,
because of the short length, reads can be aligned to multiple locations of the genome (or
transcriptome). The ambiguity resulting from multiple-aligned reads can affect the subse-
quent steps, such as assembly and expression quantification [23].
For RNA-seq, sequence assembly refers to reconstructing transcript through align-
ing and merging the short reads. Sequence assembly methods can be divided into two
categories, genome-guided assembly and de novo assembly [24]. Genome-guided as-
sembly requires sequence alignment and genome annotation to reconstruct transcripts,
which has been a prevalent approach for model organisms, and several pipelines such as
Tophat/Cufflinks [25] and HISAT/StringTie [26] are in common use. As previously men-
tioned, genome-guided assembly can be biased by multiple-aligned reads [23]. De novo
assembly does not require prior knowledge, which is especially helpful for non-model or-
ganisms without reference genome. Several de novo assembly methods such as Trans-
ABySS [27] and Trinity [28] are available, and both of them are based on constructing
de Bruijn graphs with the kmers of short reads [27, 28], which can reconstruct a tran-
script without reference genome. However, de novo assembly methods tend to be time-
and resource-consuming [28]. Although sequence assembly methods provide approaches
for reconstruct transcripts from RNA-seq dataset, reconstructing full-length transcripts still
remains a challenge. According to an assessment of various RNA-seq assembly methods,
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the best-performing unguided assembly tools can identify at most 59% full-length mRNAs
from C. elegans and only 21% from H. sapiens datasets, and over 30% in C. elegans and
60% in H. sapiens reconstructed transcripts are of partial-length [29], where partial-length
transcripts can lead to partial-length coding sequence and thus affect the classification of
transcripts into mRNAs or noncoding RNAs.
One of the key application of RNA-seq is gene (or transcript) expression estimation.
After aligning reads to a reference genome or transcriptome, the next step is to quantify
gene expression. There are also many tools for expression quantification such as HTseq
[30], RSEM [31], Cufflinks [25], and StringTie [32]. HTseq can count the reads map-
ping to genes or transcripts and return raw read counts. However, the raw read counts can
not be used alone for quantifying expression level among samples, since these values are
influenced by many factors like transcript length and sequencing depth and biases [33].
Therefore, to generate comparable expression quantification, expression normalization is
necessary [34]. For example, Reads Per Kilobase Million (RPKM) [2] and Transcripts Per
Kilobase Million (TPM) are two common normalization methods [34, 35], which can be
computed as Equations 1.1 and 1.2, respectively. Unlike HTseq, which outputs raw read
counts, RSEM, Cufflinks, and StringTie use sophisticated algorithms to estimate expres-
sion levels. For example, RSEM computes maximum likelihood abundance estimates for
transcripts using the Expectation-Maximization (EM) algorithm, which can address the un-
certainty introduced by multiple-aligned reads [31], while the time cost of RSEM can be
very expensive. If the only target is gene expression estimation, sequence alignment is not
necessary, and thus several alignment-free (or light alignment) quantification methods have
been developed based on bloom filter, such as Sailfish [36], RNA-skim [37], Salmon [38]
and kallisto [39], which are much faster than the above methods.
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After gene expression quantification and normalization, the next step is to identify dif-
ferentially expressed genes (DEGs) among samples. There are also many DEG detection
tools, such as DEGseq [40], DEseq [41], edgeR [42], and Ballgown [43]. Although the
aforementioned normalization methods (RPKM and TPM) can help to normalize the dif-
ference of sequence depth and library size between samples, it might be not adequate for
DEG detection [44]. For example, even if the sequence depth and library size are identi-
cal between samples, highly expressed genes in a sample can repress the counts for other
genes, when compared to a sample where genes are more evenly distributed, many genes
can be falsely identified as differentially expressed [44]. Therefore, DEG detection tools are
usually shipped with further normalization methods, such as edgeR (released with TMM)
[45] and DEseq. Most of DEG detection tools assume that the gene expression conforms
Poisson or Negative Binomial distribution, and then fit and test for differential expression.
Soneson, C. benchmarked eleven DEG tools, however, no optimal method was found under
all circumstances, and thus the choice of method depends on various conditions [44].
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1.2 Introduction to long noncoding RNA
Facilitated by high-throughput sequencing technologies, the investigations on genomics
and transcriptomics have shed light on the previously known “junk DNA”, which accounts
for a large proportion of the genome [46] and used to represent “any DNA sequence that
does not play a functional role in development, physiology, or some other organism-level
capacity” [46]. However, it has been estimated that approximately three-quarters of human
genome is pervasively transcribed, of which less than 2% encodes for proteins [47, 48, 49].
In other words, a large fraction of the genome is transcribed into noncoding RNAs, and the
majority are lncRNAs. Studies have revealed that lncRNAs play important biological roles
in transcription, dosage compensation, genomic imprinting, cell differentiation [47, 50],
and have been implicated in various human disease such as cancers (e.g., breast cancer,
melanoma) [51], indicating the junk DNA is not “junk”. As a key component of transcrip-
tome, long noncoding RNA (lncRNA) is defined as noncoding RNA whose length is above
200 nt, and some “classic” ncRNAs are not included, such as ribosomal RNA (rRNA) and
transfer RNA (tRNA) [52].
1.2.1 The functions of lncRNA
The functions of lncRNA are diverse and complicated. Initially, lncRNAs were considered
to be primarily associated with the epigenetic regulation [53], such as well-studied HO-
TAIR and XIST. For example, interacting with Polycomb Repressive Complex 2 (PRC2)
and the CoREST-LSD1 complex, lncRNA HOTAIR specifies the pattern of histone mod-
ification on target genes and is required for PRC2 occupancy and histone H3 lysine-27
trimethylation of HOXD locus [54, 55]. As an essential lncRNA required for X chromo-
some inactivation, lncRNA XIST can interact with 81 proteins from chromatin modifica-
tion, nuclear matrix, and RNA remodeling pathways to induce gene silencing [56]. Recent
studies revealed that the functions of lncRNAs are more than epigenetic regulation. Con-
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sidering the processes that many lncRNAs experience during their lifetime, the functions of
lncRNAs can be involved in transcriptional regulation (e.g., DEANR1), post-transcriptional
processing (e.g., lincRNA-p21), and some non-regulatory functions (e.g., PANDA) [53].
lncRNA DEANR1 can positively regulate the expression of the endoderm factor FOXA2
and then facilitate endoderm differentiation [57]. lncRNA lincRNA-p21 can selectively
associated with JUNB and CTNNB1 mRNAs and represses their translation, acting as a
post-transcriptional inhibitor of translation [58]. Interacted with the transcription factor
NF-YA, lncRNA PANDA can impede the activation of pro-apoptotic gene expression [59].
lncRNAs can interact with DNAs, RNAs, and proteins, among which the lncRNA-
protein interactions are confirmed to be the first and principle interactions and functions
for lncRNAs, such HOTAIR and XIST [60, 61]. Several mechanisms of lncRNA binding
to proteins have been discussed, where lncRNAs act as decoys, scaffolds, and guides [50,
62]. Interacting with DNA-binding proteins, lncRNAs can prevent the access of proteins
to DNA by serving as decoys [62]. One example is the aforementioned lncRNA PANDA,
which interacts with the translation factor NF-YA and prevents its binding to chromatin
[59]. Besides, acting as scaffolds, lncRNAs can bring several proteins into discrete com-
plexes [50, 62], such as the previously mentioned lncRNA HOTAIR, which associates with
PRC2 and CoREST-LSD complex to specify the correct functions [54, 55]. Moreover,
lncRNAs can act as guides to direct the appropriate localization of specific protein com-
plexes [62]. For instance, lncRNA lincRNA-p21 represses transcription through physically
association with nuclear factor hnRNP-K and modulating hnRNP-K to proper localization
[63].
1.2.2 lncRNA identification
Despite that some lncRNAs have been studied, the functions of most lncRNAs remain
unclear. Further characterizing lncRNAs will improve the understanding of transcrip-
tomics. To characterize lncRNAs, two issues are essential to be addressed, lncRNA iden-
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tification and functional annotation. lncRNA identification refers to distinguish lncRNAs
from protein-coding transcripts (also known as mRNAs), for instance, identifying lncR-
NAs from the assembled transcripts of a RNA-seq dataset. There are two kinds of methods
for lncRNA identification (or assessing the coding potential of transcripts), experimental
and computational methods. Usually, experimental methods are used to assess the cod-
ing potential of transcripts or test whether a transcript can be translated into proteins [64],
which are limited to small-scale. For example, if the function of the transcript is known,
researchers can test if the transcript can still exert function when its putative ORFs are
perturbed [64, 65]. If the function is unknown, an alternative approach is to test if the
transcript can be translated into proteins in vitro, while the drawback is that translation in
vitro does not warrant translation in vivo [64]. Moreover, translation does not necessarily
indicate function, as some translated peptides can be unstable.
To identify lncRNAs from high-throughput dataset, computational methods, which can
identify lncRNAs in large-scale, are preferred than experimental methods. Current compu-
tational methods usually integrate multiple features (such as ORF length, nucleotide kmer
frequency, and conservation features) to asses the coding potential of transcripts [66, 67,
64]. According to the dependence on alignment, lncRNA identification methods can be
divided into two categories, alignment-free and alignment-based methods [68]. For in-
stance, CPC [69] and PhyloCSF [70] are alignment-based methods, where CPC requires
aligning transcripts to protein databases with BLAST, and PhyloCSF needs multiple se-
quence alignment to compute the conservation score. CNCI [66], CPAT [67], and PLEK
[71] are alignment-free methods. Compared with alignment-free methods, alignment-based
methods are less time-effective. From the aspect of relying on reference genome annota-
tion, lncRNA identification methods can be divided into reference-free and reference-based
methods. For example, lncRScan-SVM [72] integrates features (such as exon length and
count) into a support vector machine (SVM). To extract the features of exon length and
count, a reference genome with annotation is required. Reference-based methods can suf-
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fer limitations for non-model organisms lacking whole genome sequence or comprehensive
gene annotation. A detailed introduction to these computational methods is given in Chap-
ter 2. Although several lncRNA identification methods have been developed, however,
identifying lncRNA still remains a challenge, since lncRNA and mRNAs share many sim-
ilarities, such as transcript length, poly A tails, and splicing structures. Besides, as afore-
mentioned, because of the short length of reads from next-generation sequencing technolo-
gies, it is difficult to reconstruct full-length transcripts from RNA-seq dataset [29]. If the
reconstructed partial-length mRNAs contain only partial coding sequence, they tend to be
misclassified into lncRNAs. In other words, lncRNA identification is further complicated
by partial-length transcripts.
1.2.3 lncRNA functional annotation
After identifying lncRNAs, the next step is to annotate their functions. Annotating the
functions is not simple, as the functions of lncRNAs are complicated. As aforementioned,
lncRNAs can interact with DNAs, RNAs, and proteins, and the lncRNA-protein interac-
tions are confirmed to play crucial roles in the functions of lncRNAs. Therefore, some
methods are proposed to infer the functions by investigating lncRNA-protein interactions,
including experimental and computational methods. There are several experimental meth-
ods, such as RNA immunoprecipitation (RIP), UV cross-linking and immunoprecipitation
(CLIP), and Chromatin Isolation by RNA purification (ChIRP) [73]. RIP is a technique
to detect protein-RNA interactions in vivo based on the immunoprecipitation of a target
protein, where formaldehyde is used to treat live cells and generate protein-RNA cross-
links [74]. Several PRC2-interacting lncRNAs were discovered by RIP, such as Xist, Tsix,
and RepA [75]. CLIP is also an technique to identify protein-RNA interactions related
to RNA immunoprecipitation, however, CLIP uses ultraviolet light (UV) for cross-linking
and can give the positional information for binding site [76]. Contrasted to RIP and CLIP,
which are antibody-based techniques studying the proteins of interest, ChIRP is a tech-
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nique to investigate a certain lncRNA. ChIRP uses antisense biotinylated oligonucleotides,
which are complementary to the target lncRNAs, to capture the target lncRNA-protein-
chromatin complex for protein analysis or DNA sequencing [77, 78]. For instance, ChIRP
was used to investigate the binding sites of HOTAIR on chromatin, and it was observed
that the occupancy of HOTAIR did not rely on protein EZH2 “when recruiting PRC2 to its
targets genes” [78]. Apart from investigating the interactions between lncRNAs and pro-
teins/RNAs/DNAs, recently, CRISPR was used to control the transcriptional activation or
gene expression, which are alternative approaches for studying the functions of lncRNAs
[79, 80].
Although experimental methods are promising, they are expensive and time-consuming.
In contrast, computational methods are faster and more convenient, which can also provide
helpful information for the functions of lncRNAs. Computational methods can be divided
into two categories, expression-based and expression-free methods, where expression-based
methods require the expression profile of lncRNAs, which are usually from RNA-seq
datasets. Several databases and tools used expression-based methods to predict the func-
tions of lncRNAs, such as LncRNA2Function [81], FARNA [82] and IRWRLDA [83].
lncRNA2function inferred the functions of lncRNAs by analyzing the expression correla-
tion between lncRNAs and mRNAs, where the lncRNA-coexpressed mRNAs can be used
for functional terms enrichment analysis [81]. FARNA is also based on the coexpression
analysis between lncRNAs and transcription factors (and transcription-factor co-factors)
[82]. IRWRLDA integrates lncRNA-expression similarity, disease semantic similarity,
lncRNA-disease associations into a similarity network and infer novel lncRNA-disease
associations [83]. However, expression-based methods can suffer some drawbacks, for
example, if few coexpressed mRNAs (or translation factor) of the target lncRNA are lo-
cated, expression-based methods cannot provide satisfactory functional annotation for the
target lncRNA. In contrast, expression-free methods do not rely on the expression profiles
and usually predict the interactions between lncRNAs and DNAs/RNAs/proteins, such as
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LongTarget [84], lncTar [85], and lncPro [86]. Based on Hoogsteen base-pairing analysis,
LongTarget predicts lncRNA-DNA binding sites and motifs [84]. lncTar predicts lncRNA-
RNA interactions by computing the normalized free energy of a paired RNAs [85]. lncPro
uses the structure information of lncRNAs and proteins to predict their interactions [86].
However, some expression-free methods do not provide executable tools and cannot pro-
vide detailed functional annotations, increasing the difficulty for users to apply these meth-
ods on novel lncRNAs. In a few words, computational methods can be used to guide the
experiments, for example, researchers can conduct CLIP to verify the predicted lncRNA-
interacting proteins.
1.3 Neural networks and deep learning methods
Consisting of multiple processing layers for learning representations of data, deep learning
methods have improved the state-of-the-art in many domains, such as speech recognition,
visual object recognition and bioinformatics [87]. Compared with the shallow machine
learning architectures (such as SVM and logistic regression), deep learning methods are
better at discovering intricate hidden structures in high-dimensional data, which is particu-
lar helpful for classification problems in bioinformatics [88, 89].
1.3.1 Neural networks and back propagation
Deep learning methods are based on multilayer neural networks, which can be trained with
back propagation [87, 90]. Here is a brief introduction to a simple neural network and back
propagation (Figure 1.2). The neural network in Figure 1.2 is composed of one input layer,
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Figure 1.2: The architecture of a simple neural network.






where x refers to the input vector, Wl represents the weight parameters associated with
the layers l − 1 and l, al denotes the activation vector of layer l, tw(x) is the output of the
neural network, and σ is the activation function. For simplicity, the bias term is omitted
here. Many choices are available for the activation function, such as logistic function, tanh







ReLU(x) = max(0, x)
(1.4)
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After feedforwarding the input (x) to the neural network, the output (tw(x)) will be
generated. To train the neural network, the target is to minimize the discrepancy (cost
function) between the output (tw(x)) and the desired output (y), which can be done with
back propagation [90]. Cross-entropy function is a common used cost function for binary
classification problem and can be computed as follows:
C = − 1
n
∑
[y ln tw(x) + (1− y) ln(1− tw(x))] , (1.5)
where n denotes the total number of input items in training data. To minimize the cost
function, gradient descent can be used to update the weight parameters, such that:
wτ+1 = wτ − η∇C(wτ ) (1.6)
where wτ refers to the weight parameters at iteration τ , and η is the learning rate. Here,∇C
need be computed for each layer using back propagation. First, consider the last layer L
and use the chain rule (suppose using logistic function as activation function). To simplify




















can be explicitly computed, we only need to focus on ∂C
∂zL










= y − t (1.8)
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The weight parameters can then be updated using Equation 1.6.
As an efficient procedure for multiple-layer neural network training, back propagation
has been used in many deep learning architectures, such as deep belief network (back prop-
agation is used to finetune the network) [92], convolutional neural network [93], and recur-
rent neural network [94]. Various deep learning architectures offer alternative approaches
to further improve the classification performance apart from novel models.
1.3.2 Deep belief network
Herein, we give a brief introduction to deep belief network (DBN) [92]. As a generative
graph model, DBN was proposed around 2006 by Hinton, Geoffrey et al. [92] and worked
well on many applications, such as recognizing handwritten digits and speech recognition
[92, 95, 96]. A DBN is built as a stack of restricted Boltzmann machines (RBMs) [92, 89],
and a RBM (Figure 1.3) is a kind of energy-based model composed of one layer of hidden
variables and one layer of observed variables [92, 89, 97].







Figure 1.3: The graph model of a RBM.







x,h exp(−E(x,h)) and the energy function is defined as:
E(x,h) = −b′x− c′h− h′Wx (1.12)






For a Bernoulli (hidden)-Bernoulli (observed) RBM (i.e., hi ∈ {0, 1} ,xi ∈ {0, 1}), the
conditional probabilities can be computed as:
p(hi = 1|x) = σ(ci +Wix), p(xj = 1|h) = σ(bj +W ′.jh) (1.14)
where σ(x) = 1/(1 + exp(x)) and W ′.j denotes the jth column of W . To estimate the
parameters θ of P (x), our target is to maximize P (x) with maximum likelihood estimation.
Thus, to use gradient descent method, we need compute the gradient of the log likelihood
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Therefore, the weight W can be updated with the following rule:
∆Wij = ExpectationP (x,h)(hixj)− ExpectationP (x|h)(hixj) (1.17)
The parameters b and c can be updated similarly. To update the parameters, hixj can be cal-
culated through sampling from P (x,h) and P (x|h). As for a Bernoulli (hidden)-Bernoulli
(observed) RBM, the conditional probabilities are analytically available (Equation 1.14),







However, MCMC tends to be time-expensive and therefore an approximate sampling strat-
egy known as contrastive divergence (usually one step of sampling is adequate) was pro-
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posed, which can be referred to in [92]. Stacking a number of the RBMs learned layer by
layer from bottom-up gives rise to a DBN (Figure 1.4), and one immediate advantage of
DBN is that even unlabeled dataset can be used for pre-training the neural network and
then obtaining a good initialization point [92, 87, 99]. After initialization, an output layer
can be added and then the whole neural network can be fine-tuned with back propagation.













Figure 1.4: The structure of a DBN.
1.4 Introduction to the contents of this dissertation
lncRNAs play important biological roles and have been implicated in disease such as can-
cer. At present, RNA sequencing has become a prevalent method to study transcriptome,
especially lncRNAs. To comprehensively annotate newly discovered transcripts, the first
step is to distinguish lncRNAs from mRNAs. Although several lncRNA identification tools
are available, most of them focus on identifying lncRNAs from full-length transcripts,
while transcripts assembled from RNA-seq data are composed of full- and partial-length,
limiting their applications and performance. To exert biological functions, lncRNAs can
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interact with DNAs, RNAs, and proteins (lncRNA-protein interactions). Among the three
categories of interactions, lncRNA-protein interactions play crucial roles in the function-
ing of lncRNA, providing details of how lncRNAs exert functions in various biological
processes. Although there are several methods for predicting lncRNA-protein interactions,
they can not give functional annotations for lncRNAs, except outputting the interaction
results. Recently, deep learning methods have improved the state-of-the-art performance
in many areas, and it is appealing to employ deep learning methods into bioinformatics,
such as characterizing lncRNAs. To meet the urgent demand for studying lncRNAs, in
this dissertation, we develop a novel lncRNA identification and functionally annotation
tool named LncADeep (http://cqb.pku.edu.cn/ZhuLab/LncADeep), based on deep learning
methods. Herein, we give a brief introduction for the contents of this dissertation.
(i) Identify lncRNA with deep learning. First, we develop a novel method for lncRNA
identification (implemented as LncADeep), improving the accuracy of identifying lncR-
NAs. As a widespread method for studying lncRNAs, current RNA-seq techniques are
mainly based on next-generation sequencing technologies and tend to generate short reads,
which impedes the accurate reconstruction of full-length transcript. Thus, the partial-length
mRNAs assembled from RNA-seq short reads further complicate the identification of lncR-
NAs, as partial-length mRNAs truncated at 5’ and/or 3’ end can result in incomplete cod-
ing sequences, which are much likely to be misclassified into lncRNAs. Moreover, in real
dataset consisting of lncRNAs and full- and partial-length mRNAs, it is unclear whether
any given transcript is of full- or partial-length, therefore, the composition of full- and
partial-length mRNAs is unknown and varies case by case. As the composition of full- and
partial- length mRNAs in training dataset can affect the performance of lncRNA identifi-
cation on test dataset, the classifier trained on the dataset with an arbitrary composition of
full- and partial-length mRNAs might not perform well on real dataset. To address these
challenges, we propose a novel lncRNA identification method by integrating sequence in-
trinsic and homology features based on deep belief networks. Particularly, we construct two
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models for lncRNA identification, one targeting full-length transcripts and the other target-
ing transcripts including full- and partial-length. Furthermore, we employ majority voting
to avoid using a classifier trained on the dataset with an arbitrary composition of full- and
partial-length mRNAs. Based on a comprehensive benchmark with eleven state-of-the-art
lncRNA identification tools, CPC [69], CPC2 [100], CPAT [67], CNCI [66], PLEK [71],
lncRScan-SVM [72], lncRNA-MFDL [101], COME [102], longdist [103], lncScore [104],
and FEElnc [105], our proposed tool LncADeep has outperformed them on full-length hu-
man transcripts with an average accuracy of 97.7% (sensitivity 98.1%, specificity 97.2%),
and transcripts including full- and partial-length with an average accuracy of 94.2% (sensi-
tivity 93.8%, specificity 94.5%). In addition, LncADeep still achieved better performance
than the above tools on cross-species lncRNA identification on full-length mouse tran-
scripts with an accuracy of 96.7% (sensitivity 97.0%, specificity 96.3%) and transcripts
including full- and partial-length with an accuracy of 94.2% (sensitivity 95.1%, specificity
93.3%).
(ii) Predict lncRNA-protein interactions and infer lncRNA functions. Second, as lncRNA-
protein interactions play the critical roles in the functioning of lncRNAs, we develop a
method for predicting lncRNA-protein interactions and then the predicted interacting pro-
teins are used for annotating the functions of lncRNAs (implemented as LncADeep). To
predict lncRNA-protein interactions, we integrate sequence and structure features of lncR-
NAs and proteins, which are fed into deep neural networks to build a binary classifier.
Based on a comprehensive benchmark with state-of-the-art tools (i.e., lncPro [86], RPISeq
[106], RPI-pred [107], rpiCool [108] and IPMiner [109]), LncADeep has outperformed
them with the highest accuracy of 90.8% (sensitivity 97.0%, specificity 85.4%). After pre-
dicting the interacting proteins of lncRNAs, LncADeep conducts KEGG and Reactome
pathway enrichment analysis and functional module detection to infer the functions of
lncRNAs. Therefore, apart from predicting lncRNA-protein interaction with better per-
formance, LncADeep can provide functional annotations for lncRNA automatically, show-
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ing noticeable advantages over the above five tools. We then use LncADeep to anno-
tate the 27,384 lncRNAs collected by GENCODE database, and results have shown that
LncADeep annotated each lncRNA with an average of 25 KEGG and 67 Reactome path-
ways, which are more abundant than the annotations resulted from IPMiner’s predicted
proteins for enrichment analysis. Moreover, for lack of a gold standard dataset for lncRNA
functions, we took several well-studied lncRNAs as examples by comparing their inferred
functions (by LncADeep) with the reported functions from literatures. Case studies show
that LncADeep’s functional annotations for lncRNAs conform with their known functions.
In summary, we develop a novel lncRNA identification and functional annotation tool,
LncADeep, which integrates the above two proposed methods, i.e., (i) identify lncRNA
with deep learning and (ii) predict lncRNA-protein interactions and infer lncRNA func-
tions. LncADeep (http://cqb.pku.edu.cn/ZhuLab/LncADeep/) is freely available for non-
commercial use. As an executable tool, LncADeep has two distinctive characteristics.
First, LncADeep outperformed state-of-the-art lncRNA identification tools on full-length
transcripts and transcripts including full- and partial-length, which is particularly useful for
identifying lncRNAs from RNA-seq dataset. Second, LncADeep outperformed state-of-
the-art tools on predicting lncRNA-protein interactions and can provide informative func-
tional annotations, which comply with the known functions, for lncRNAs. As far as we
know, LncADeep is the first tool which can identify lncRNA and annotate lncRNAs func-
tions automatically. It is expected that LncADeep can not only identify lncRNAs with high
performance, but also offer informative functional annotations for studying the associa-
tions among lncRNAs, gene regulation and diseases, and further facilitate the large-scale
automatic genome annotation.
The rest of this dissertation is organized as follows. Chapter 2 describes the novel
method we developed for lncRNA identification. Chapter 3 introduces the method we de-
signed for predicting lncRNA-protein interactions and inferring the functions of lncRNAs.
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Each of these chapters gives introduction and motivation, describes materials and methods
for the study, and presents results and discussions. In the end, apart from giving an illus-
tration for the application of LncADeep on an RNA-seq dataset, Chapter 4 concludes this
dissertation. In addition to developing LncADeep for lncRNA identification and functional
annotation, we investigate the impact of RNA-seq aligners on DEG detection and gene
expression estimation, since sequence alignment is a key step in RNA-seq data analysis,
and the accuracy of alignment will profoundly affect the subsequent analysis. As these are
the minor part of this dissertation, we present them in Appendices. Appendix A and B




IDENTIFY LNCRNA WITH DEEP LEARNING
Long noncoding RNAs play important biological roles and have been implicated in various
human diseases. To characterize lncRNAs, identifying and annotating lncRNAs is neces-
sary. This chapter describes the method we proposed for identifying lncRNAs based on
a deep learning algorithm. The proposed lncRNA identification method has been imple-
mented into the tool named LncADeep (http://cqb.pku.edu.cn/ZhuLab/LncADeep).
2.1 Introduction
While approximately three quarters of human genome is pervasively transcribed, less than
2% encodes for proteins [47, 48, 49], indicating a large proportion of the genome is tran-
scribed into noncoding RNAs. As the majority of noncoding RNAs, long noncoding RNAs
(lncRNAs, length above 200 nt) [47] play important biological roles in dosage compensa-
tion, genomic imprinting, cell differentiation [47, 50], and have been implicated in human
disease such as cancers [51]. Although some lncRNAs have been characterized, the func-
tions of most lncRNAs currently remain unclear [48].
To comprehensively characterize newly discovered transcripts, two issues are required
to be addressed: identifying lncRNAs and inferring their functions. As the first step,
lncRNA identification still remains a challenge. First of all, lncRNAs and mRNAs share
many similarities such as transcript length and splicing structure [110, 50], which compli-
cate lncRNA identification. Facilitated by high-throughput sequencing technologies, RNA
sequencing (RNA-seq) has become a prevalent method for studying lncRNAs [111]. How-
ever, accurate full-length transcript assembly is impeded by the short reads from current
RNA-seq techniques [29]. For example, according to an assessment, the best-performing
unguided assembly methods identified only 21% full-length mRNAs from human datasets,
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and over 60% of reconstructed transcripts were of partial-length [29]. Thus, lncRNA iden-
tification is further complicated by partial-length mRNAs reconstructed from RNA-seq
short reads (Figure 2.1), since partial-length mRNAs truncated at 5’ and/or 3’ end can lead
to incomplete coding sequences (CDS), which are prone to be misclassified as lncRNAs.
Moreover, in real dataset consisting of lncRNAs and full- and partial-length mRNAs, it is
unclear whether any given transcript is of full- or partial-length, therefore, the composition
of full- and partial-length mRNAs is unknown and varies case by case. As the composi-
tion of full- and partial-length mRNAs in training dataset can affect the performance of
lncRNA identification on test dataset, the classifier trained on the dataset with an arbitrary
composition of full- and partial-length mRNAs might not perform well on real dataset.
5’ UTR Coding Sequence (CDS) 3’ UTR
Full-length mRNA
5’ UTR CDS or Incomplete CDS
Partial-length mRNA CDS or Incomplete CDS 3’ UTR
CDS or Incomplete CDS
Figure 2.1: The structures of reconstructed full- and partial-length mRNAs.
lncRNA identification methods can be divided into two categories, reference-based and
reference-free methods, where reference-based methods require comprehensive reference
genome annotation (Table 2.1). lncRScan-SVM [72], COME [102], PhyloCSF [70], and
lncScore [104] are reference-based methods. lncRScan-SVM combines features (such as
exon length and count and PhastCons score) into a support vector machine (SVM) to clas-
sify lncRNAs and mRNAs. To extract the features, such as exon length and count, aligning
the transcripts to a reference genome with annotation is necessary. COME [102] inte-
grates sequence-derived, expression, and histone features into a Random Forest classifier
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CPC SVM No 2007 Nucleic Acids Res
CPC2 SVM No 2017 Nucleic Acids Res
PhyloCSF* Phylogenetic model Yes 2011 Bioinformatics
CPAT Logistic Regression No 2013 Nucleic Acids Res
CNCI SVM No 2013 Nucleic Acids Res
PLEK SVM No 2014 BMC Bioinformatics




No 2015 Molecular Biosystem
lncRScan-SVM SVM Yes 2015 PLOS one
COME Random forest Yes 2016 Nucleic Acids Res
lncScore Logistic Regression Yes 2016 Scientific Reports
FEElnc Random forest No 2017 Nucleic Acids Res
longdist SVM No 2017 BMC Genomics
LncADeep Deep belief networks No 2017 This dissertation
	
for lncRNA identification, requiring genome annotation and experimental datasets to index
the reference genome and to align the transcript to reference genome. PhyloCSF [70] ap-
plies multiple sequence alignment, which requires reference genome annotation, to calcu-
late phylogenetic conservation score. lncScore [104] employs features (i.e., features from
exon, maximum coding subsequence, and ORF) into logistical regression, and also con-
siders the existence of partial-length mRNAs assembled from RNA-seq data. To extract
features from exons, lncScore requires aligning transcripts to the reference genome with
annotation. Reference-based methods can suffer limitations for non-model organisms lack-
ing whole-genome sequence or comprehensive reference gene annotation [66, 68]. Even
though the reference genome and genome annotation are available, the potential multiple-
mapping of a transcript can complicate the feature extraction, thus affecting the subsequent
lncRNA identification.
CPC [69], lncRNA-ID [68], CPAT [67], CPC2 [100], CNCI [66], PLEK [71], FEElnc
[105], longdist [103], and lncRNA-MFDL [101] are reference-free methods. CPC [69]
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employs BLAST to align transcripts to known protein databases, with an underlying as-
sumption that noncoding transcripts tend to share less sequence conservation than homol-
ogous mRNAs. lncRNA-ID [68] takes advantage of profile hidden Markov model-based
alignment [112], however, lncRNA-ID does not provide an executable tool, limiting its ap-
plication. CPAT [67] incorporates linguistic features of transcript sequence into a logistic
regression model to assess coding potential. As an updated version of CPC [69], CPC2
[100] employs sequence intrinsic features with SVM. CNCI [66] distinguishes lncRNAs
from mRNAs by profiling adjoining nucleotide triplets with SVM. Longdist [103] em-
ploys PCA to select k-mer based features and identifies lncRNAs using SVM. PLEK [71]
classifies lncRNAs and mRNAs with SVM using k-mer based features. FEElnc [105] em-
ploys k-mer frequencies and relaxed open reading frames to predict lncRNA with Random
forests. lncRNA-MFDL [101] identifies lncRNAs by integrating linguistic features and
predicted secondary structures into deep stacking networks. However, RNA structure pre-
diction is error-prone, computational expensive, and the accuracy is often unsatisfactory
for RNAs longer than 1000 nt [113] , and might introduce unexpected effects to the sub-
sequent lncRNA identification. Besides, predicting secondary structure is computational
expensive: the time complexity of RNAfold [113] used by lncRNA-MFDL is O(L3), where
L is the length of RNA sequence.
Most of the above methods focus on only full-length transcripts. Although CNCI, lnc-
Score and FEElnc realized the existence of partial-length mRNAs, they did not consider
the various compositions of full- and partial-length mRNAs in real dataset and used only
an arbitrary composition of full- and partial-length mRNAs for training, which could affect
the performance of lncRNA identification.
With the development of high throughput sequencing technology, a large amount of
transcripts will be sequenced and require functional annotation. To fulfill the requirements,
we present LncADeep, which can not only identify lncRNAs, but also infer the functions of
lncRNAs, while no tools can accomplish both. This chapter focuses on lncRNA identifica-
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tion, where LncADeep integrates sequence intrinsic features (e.g., entropy density profile)
and homology features (i.e., profile hidden Markov model-based alignment) into a deep
belief network, improving the accuracy of identifying lncRNAs. Herein, we construct two
models for lncRNA identification, one targeting full-length transcripts and the other tar-
geting transcripts including full- and partial-length. Identifying lncRNAs from full-length
transcripts will be useful when the third-generation sequencing technologies, which suf-
fice generating full-length transcripts, are prevalent. Moreover, we propose to use majority
voting to avoid using a classifier trained on the dataset with an arbitrary composition of
full- and partial-length mRNAs. To our knowledge, LncADeep is the first tool consider-
ing the various compositions of full- and partial-length mRNAs in dataset. LncADeep has
outperformed state-of-the-art tools including CNCI, COME, CPC, CPC2, CPAT, FEElnc,
lncRNA-MFDL, longdist, lncRScan-SVM, lncScore and PLEK on full-length transcripts,
transcripts including full- and partial-length, and cross-species lncRNA identification.
2.2 Materials and methods
2.2.1 Data description
Currently both RefSeq [114] and GENCODE [48, 115] provide comprehensive and well-
annotated sequences for mRNAs and lncRNAs. In particular, the human mRNAs in RefSeq
are of full-length. However there are about 36% of human mRNAs in GENCODE (Release
24) are of partial-length, which are mainly owning to the challenges of transcript assem-
bling from high-throughput sequenced RNA-seq data [115]. Herein, full-length mRNAs
contains 5’ untranslated region (UTR), CDS, and 3’ UTR, while partial-length mRNAs can
miss 5’ UTR or 3’ UTR, and the CDS can also be incomplete (Figure 2.1).
As aforementioned, we constructed two models for lncRNA identification, one target-
ing full-length transcripts and another targeting transcripts including both full- and partial-
length ones. In particular, full-length transcripts are composed of lncRNAs and full-length
mRNAs, and transcripts including full- and partial-length consist of lncRNAs and full- and
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partial-length mRNAs. Full-length human mRNAs were collected from RefSeq Release
75, while mRNAs including full- and partial-length and lncRNAs were from GENCODE
Release 24. To remove similar and redundant transcripts, we used CD-HIT [116] to keep
only the representative ones (Table 2.2). After removing short transcripts (length less than
200 nt), we finally obtained 38,679 mRNAs from RefSeq (all full-length), and 91,752 mR-
NAs (including 58,528 full-length and 33,224 partial-length) and 27,384 lncRNAs from
GENCODE (Table 2.3). To assess the performance of cross-species lncRNA identification,
we collected transcripts for mouse, as its experimentally verified mRNAs and lncRNAs
are more abundant compared with those of other species. Herein 29,739 full-length mouse
mRNAs were collected from RefSeq Release 75, while 56,744 mRNAs (39,079 full-length
and 17,665 partial-length) and 12,529 lncRNAs were collected from GENCODE Release
M9 (Table 2.4).
Table 2.3: Human dataset for lncRNA identification
Type Source Number




91,752 (58,528 full-length and 
33,224 partial-length)
Full-length mRNA RefSeq Release 75 38,679
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Table 2.4: Mouse dataset for lncRNA identification
Type Source Number




56,744 (39,079 full-length and 17,665 
partial-length)
Full-length mRNA RefSeq Release 75 29,739
	
2.2.2 Methods
To identify lncRNA, we integrate several sequence and homology features as predictor
variables into a deep belief network of deep learning architecture and construct two models
shown in Figure 2.2. For the model targeting full-length transcripts, we use the following
features including ORF length and coverage, the EDP of ORF, Mean hexamer score, UTR























Figure 2.2: The flowchart of lncRNA identification.
We construct two models for lncRNA identification, one for full-length transcripts, and the other
for transcripts including full- and partial-length. F1 to F6 refer to ORF length and coverage, the
EDP of ORF, Mean hexamer score, Fickett nucleotide features, HMMER index, and UTR length
and GC content, respectively. f1 to f3 represent LCDS length and coverage, the EDP of LCDS,
and Mean hexamer score, respectively.
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ORF length and coverage
Open reading frame (ORF) is one of the most fundamental criteria to distinguish lncRNAs
from mRNAs, since lncRNAs tend to have shorter ORFs or lower ORF proportion than
mRNAs [67, 68]. Therefore, we use two features, ORF length and coverage. The ORF
length is defined as the length of the longest ORF (LORF) detected in three forward frames,
starting with a start codon (ATG) and ending with a stop codon (TAG, TAA, or TGA). The
ORF coverage is the ratio of the ORF length to the transcript length.
The EDP of ORF
In our previous studies of prokaryotic gene prediction, the entropy density profile (EDP)
model was used to assess the coding potential of ORFs based on the amino acid compo-
sition [117, 118]. The success of EDP model supports the hypothesis that protein-coding
and noncoding ORFs distribute separately in the EDP phase space, which might be caused
by different selection pressure during evolution [117, 118]. Similarly, we extend the EDP
model to lncRNA prediction by computing the EDP of amino acid composition of the ORF.




pi log pi (2.1)
whereH = −
∑20
j=1 pj log pj is the Shannon entropy, pj is the abundance of jth amino acid,
and i, j = 1, . . . , 20 represents the index of the twenty amino acids.
k-mer frequency has been used to characterize transcripts in several lncRNA identifi-
cation methods [67, 71, 101] and proved to be useful. Thus, apart from using the EDP
of amino acid composition, we propose to use the EDP of k-mer of the ORF as another
feature. To be specific, we choose k = 2 and obtain sixteen 2-mer patterns (e.g., AA, AC,
AG, AT, etc.). Similar to the EDP of amino acid composition of an ORF, the EDP of 2-mer
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ci log ci (2.2)
where H = −
∑16
j=1 cj log cj is the Shannon entropy, cj is the abundance of ith 2-mer, and
i, j = 1, . . . , 16 represents the index of the sixteen 2-mer. It is worth noting that the EDP
of ORF is computed on the LORF.
Mean hexamer score.
Hexamer usage is another important feature to distinguish lncRNAs from mRNAs, which
has been demonstrated in [119, 67]. Therefore, we extract the hexamer usage bias of the
LORF as another feature. For a given hexamer sequence S = H1, H2, ..., Hm, we follow
the definition of mean hexamer score as [67], which is the mean of the logarithm of the











Fc(H1) . . . Fc(Hm)










where Pc(S) and Pnc(S) represent the probability of the sequence calculated under the
model of coding RNA and noncoding RNA respectively. To compute these probabilities,
the hexamer frequency for 4,096 (46 = 4096) kinds of hexamers are required, thus Fc(hj)
and Fnc(hj) refer to in-frame hexamer frequency (j = 1, 2, . . . , 4096), computed from
coding and noncoding training datasets respectively. In particular, the coding and noncod-
ing hexamer frequency were calculated in 33,957 CDSs (extracted from RefSeq human
mRNAs, and we removed redundant CDSs) and 27,384 lncRNAs (from GENCODE), re-
spectively. Generally, protein-coding transcripts tend to show a positive hexamer score,
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and lncRNAs negative.
UTR coverage and GC content.
A typical eukaryotic full-length mRNA is composed of a 5’ untranslated region (5’ UTR), a
coding region, and a 3’ untranslated region (3’ UTR) [120]. To distinguish protein-coding
and noncoding transcripts, apart from focusing on assessing the coding potential of ORFs,
considering the untranslated regions of transcripts is necessary. For eukaryotic mRNAs, 5’
UTRs and 3’ UTRs show several noteworthy characteristics. To name a few, 3’ UTRs are
generally much longer than 5’ UTRs; the mean GC content of 3’ UTR sequences is smaller
than that of 5’ UTR [120]. Although lncRNAs can have putative ORFs, it can be rare
for lncRNAs to still contain both putative 5’ and 3’ UTRs which conform with the above
characteristics. To capture more intrinsic characteristics of transcripts, we incorporate the
features of untranslated regions. Being aware of the discrepancy of length and GC content
between 5’ and 3’ UTRs [120], we calculate the 5’ UTR and 3’ UTR coverage (i.e., the
ratio of the length of 5’ or 3’ UTR to the length of transcript sequence) and GC content
to characterize UTRs. To simplify the model, after detecting the LORF of a transcript, we
treat the upstream sequence of start codon as 5’ UTR, and the downstream sequence of stop
codon as 3’ UTR.
Fickett nucleotide features.
Fickett nucleotide features were proposed in [121], including nucleotide composition and
position frequency. The nucleotide composition is the percentage of each base contributing
to the sequence, as coding sequences tend to have higher GC content. The nucleotide
position frequency assesses the degree to which each base is favored in one codon position
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over another [121], and is defined as follows:
A1 = Number of A’s in position 1, 4, 7, . . .
A2 = Number of A’s in position 2, 5, 8, . . .
A3 = Number of A’s in position 3, 6, 9, . . .
Apos =
MAX(A1, A2, A3)
MIN(A1, A2, A3) + 1
(2.4)
Cpos, Gpos, and Tpos are computed similarly. To distinguish protein-coding and noncoding
sequence, Fickett provided a lookup table to transform these eight values to a TESTCODE
score. However, the lookup table in [121] was generated from 321 coding and 249 non-
coding sequences then. Compared with the datasets we collected, TESTCODE score from
that small data might not be adequate to characterize sequence features. Therefore, instead
of directly using TESTCODE score, we compute the nucleotide composition and position
frequency on the whole transcript.
HMMER index.
Since mRNAs are more conserved against characterized proteins than lncRNAs, homology
features, such as features derived from the output of BLAST [69] and HMMER search
[68], will also benefit lncRNA identification. Although protein sequence databases pro-
vide a wealth of resources for conservation search using BLAST, the huge search space
leads to high time cost. In contrast, using HMMER [112] search against protein families,
such as Pfam [122], has several advantages. For instance, compared with the number of
protein sequences, the number of gene families is much smaller, indicating a significantly
smaller search space and lower time cost. Therefore, we extract features from the output of
HMMER search. In particular, we align each transcript to Pfam Release 29.0 [122] using
HMMER [112]. Here, the cutoff of E-value is 0.1, and if more than one alignment is re-
ported, the alignment with the best E-value will be used. Since mRNAs are more likely to
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have higher alignment score and longer alignment region than lncRNAs, we extract three
features, the alignment score, the ratio of aligned region to the query sequence, and the
ratio of aligned region to the profile, from the chosen alignment for a transcript.
The above features (i.e., ORF length and coverage, the EDP of ORF, Mean hexamer
score, UTR coverage and GC content, Fickett nucleotide feature, and HMMER index) are
for the model of full-length transcripts.
Longest CDS.
For the model targeting transcripts including both full- and partial-length, we introduce a
feature of the longest CDS (LCDS).
Currently the RNA-seq data tends to produce transcripts mixed with a significant amount
of partial-length mRNAs, which may be easily misclassified into lncRNAs and challenge
the performance of lncRNA identification. Considering the existence of partial-length
mRNA, we first define the ORF-based CDS representing the longest ORFs with their 3’
ends missed, i.e., we search for ORFs starting with a start codon, but lacking an in-frame
stop codon. Once all the potential ORFs are detected, we choose the longest one as an
ORF-based-CDS.
Second, considering hexamer usage bias in CDS, we search for the candidate CDS with
the maximum hexamer score, which is similar to the approach in CNCI to find MLCDS
with the highest ANT score [66]. The assumption is that the sequence with higher hexamer






where Fc(hj) and Fnc(hj) (j = 1, 2, . . . , 4096) represent in-frame coding and noncoding
hexamer frequency, respectively. Thus, for a given hexamer sequence S = H1, H2, ..., Hm,
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Given a transcript, we use a dynamic programming method named Maximum Subarray
Sum (MSS) [123] to find a Hexamer-based-CDS. This method is to find a continuous in-
frame sub-hexamer sequence, which yields the maximum hexamer score (Figure 2.3). To
be specific, we consider the three forward in-frame hexamer sequences for a given tran-
script, and among the three hexamer sequences, we use MSS to find a sub-hexamer se-
quence with the largest hexamer score, which is treated as Hexamer-based-CDS.
Finally, we choose the longer one as the longest CDS (LCDS) from the ORF-based-
CDS and the Hexamer-based-CDS, with a rationale that the LCDS has the highest coverage
over the sequence and more likely to cover the true CDS. With the LCDS, we compute its
length and coverage as features, where the coverage is the ratio of the LCDS length to the
transcript length.
In addition to the LCDS length and coverage, we also use other features, including
Mean hexamer score, the EDP of LCDS, Fickett nucleotide feature, and HMMER index.
Among these features, Fickett nucleotide feature and HMMER index are computed the
same as in the model for full-length transcripts, while Mean hexamer score and the EDP
of LCDS are computed on the LCDS. We do not include the UTR feature, as partial-length
transcripts might lack 5’ or 3’ ends.
2.2.3 Deep belief network
The extracted features from each transcripts can be concatenated into a vector and then fed
to a deep learning method for training and testing. Compared with the shallow machine
learning architectures (such as SVM and logistic regression), deep learning methods are



















Figure 2.3: A toy example for finding a continuous in-frame sub-hexamer sequence yield-
ing the maximum hexamer score.
As a toy example, here we only consider the first forward in-frame Hexamer sequences. We
need to find a continuous in-frame sub-hexamer sequence, such that the sub-hexamer sequence
has the highest hexamer score. Choosing H4,H5,H6, the hexamer score will be 2.26; choosing
H8,H9,H10, the hexamer score will be 1.9. If we choose H4,H5,,H10, we can get the highest
hexamer score with 4.07.
ular helpful for classification problems [89, 88]. Many deep learning architectures have
been available, such as deep belief network (DBN), deep neural network, convolutional
neural network, and recurrent neural network [92, 87]. Various architectures offer alterna-
tive approaches to further improve the classification performance apart from novel models.
In this dissertation, we implement a DBN to identify lncRNAs. A DBN is a class of deep
neural network composed of multiple layers of latent variables, with connections between
the layers but not between units within each layer [87]. To implement, a DBN is built as
a stack of restricted Boltzmann machines (RBMs), and a RBM consists of one layer of
hidden units and one layer of observed units [92]. Stacking a number of the RBMs learned
layer by layer from bottom-up gives rise to a DBN. DBN can make use of the dataset for
pre-training and obtain a good initialization point for neural network. After initialization,
an output layer can be added and the whole neural network can be fine-tuned with back
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propagation. We construct DBN with the setting as suggested in [92, 124]: For the first
two layers, we use Gaussian (visible)-Bernoulli (hidden) RBM; while for the other layers,
we utilize Binary-Binary RBM. The architecture of deep belief network is list in Tables 2.5
and 2.6.
We use DBN to initialize the parameters of neural network and then fine-tune the neu-
ral network with back propagation. The dimensions of the features are: 2 (ORF length
and coverage) + 36 (The EDP of ORF) + 1 (Mean hexamer score) + 4 (UTR length and
coverage) + 8 (Fickett nucleotide features) + 3 (HMMER index) = 54 dimensions (Table
2.5). In the model for transcripts including full- and partial-length, we do not use the UTR
length and coverage (4 dimensions). Thus, the input dimension is 50 (Table 2.6).




Input layer: 54 nodes
Sigmoid
1st hidden layer: 10 nodes
2nd hidden layer: 10 nodes
3rd hidden layer: 10 nodes
Output layer: 1 node
	




Input layer: 50 nodes
Sigmoid
1st hidden layer: 10 nodes
2nd hidden layer: 10 nodes
3rd hidden layer: 10 nodes
Output layer: 1 node
	
2.2.4 Evaluation metrics
To evaluate the prediction performance of the LncADeep and other existing tools, we use
two independent quantities, Sn (sensitivity) and Sp (specificity), and a balanced quantity
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where TP, TN, FP, and FN represents true positive, true negative, false positive, and false
negative respectively. Herein Sn measures the ratio of actual positives that are correctly
identified, Sp measures the ratio of true positives in all predicted positives, and Hm is a
composite measure of sensitivity and specificity [118]. For lncRNA identification, lncR-
NAs are regarded as the positive class while protein-coding transcripts as the negative class.
2.3 Results
2.3.1 Performance of lncRNA identification
As a comprehensive annotation tool for lncRNA, LncADeep first aims to accurately iden-
tify lncRNAs from newly sequenced transcripts. In this subsection, we report the lncRNA
identification accuracies of our LncADeep program, and the performance comparison with
current representative tools providing executable programs, CPC [69], CPC2 [100], CPAT
[67], CNCI [66], PLEK [71], longdist [103], lncRScan-SVM [72], lncRNA-MFDL [101],
COME [102], lncScore [104], and FEElnc [105]. PhyloCSF [70] was not included since it
is time-consuming and has been outperformed by CPAT and CNCI [67, 66]. To benchmark
these tools, it is fair to re-train all programs on the same training set and test against the
same test set. Among the above tools, there are COME, CPAT, lncRScan-SVM, longdist,
PLEK and FEElnc (FEElnc requires retraining) providing model-training options, while
longdist and PLEK’s retraining is very time-consuming as mentioned in users’ manual so
we did not retrain these two programs. For the tools without any available re-training
option, namely CPC, CPC2, CNCI, lncRNA-MFDL and lncScore, we can only use their
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pre-built models.














Figure 2.4: The construction of training and test sets for full-length human transcripts.
We first compared the performance of lncRNA identification on full-length transcripts.
With 10-fold cross validation (Figure 2.4), LncADeep achieved an average sensitivity of
98.1% and specificity of 97.2%, meanwhile an average harmonic mean of 97.7%. Com-
pared with other tools with the same test sets, LncADeep had the highest specificity, and
rather a high sensitivity only slightly lower than that of CPC (however CPC’s specificity as
84.8% is much lower than LncADeep’s as 97.2%, leading to the harmonic mean of CPC as
91.3% evidently lower than LncADeep’s 97.7%). Totally, our method had the highest accu-
racy among all lncRNA identification tools, and certainly outperformed the existing tools.
The comparison of identification results by LncADeep and other tools are shown in Table
2.7. Figure 2.5 plots the mean ROC curves of all tools, and LncADeep achieves the highest
AUC of 99.71% and outperforms other tools, which is consistent with the results in Table
2.7. Among the tools compared with in the current study, it should be pointed out that the
tools, CNCI, CPC, CPC2, PLEK, lncScore and lncRNA-MFDL, have not been retrained in
the process of 10-fold cross validation. So their identification performances might be over
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Table 2.7: Comparison of performances for lncRNA identification with 10-fold cross-
validation on full-length human transcripts.
Category Tool
Full-length transcriptsa
Sn (%) Sp (%) Hm (%)
Reference-based
COME 94.3±0.3 96.0±0.3 95.1±0.2
lncScore 93.7±0.5 94.3±0.6 94.0±0.3
lncRScan-SVM 96.5±0.2 93.1±0.4 94.8±0.3
Reference-free
CPC 98.9±0.1 84.8±0.6 91.3±0.3
CNCI 97.3±0.2 88.2±0.5 92.6±0.2
CPAT 95.4±0.4 93.6±0.5 94.5±0.3
CPC2 94.4±0.5 92.4±0.5 93.4±0.4
FEElnc 96.7±0.3 95.5±0.4 96.1±0.3
PLEK 98.1±0.2 95.5±0.2 96.8±0.2
longdist 98.6±0.2 44.5±0.2 61.3±0.2
lncRNA-MFDL 93.9±0.5 94.8±0.5 94.3±0.4
LncADeep 98.1±0.2 97.2±0.3 97.7±0.2
a The dataset is from Refseq (full-length mRNAs) and GENCODE (lncRNAs). LncADeep was trained for
the model targeting full-length transcripts.
estimated since their training sets have overlap with the test sets. In particular, PLEK’s [71]
pre-built model also used mRNAs from Refseq and lncRNAs from GENCODE for train-
ing, which overlapped with the datasets we used, and this is why PLEK achieved relatively
high performance although lower than that of LncADeep.
We then report the identification performances of LncADeep applied on the transcripts
including partial-length mRNAs, which certainly has utility value for processing the real
data. Our analysis has demonstrated that the ratio of partial-length mRNAs in training set
affects the lncRNA identification performance on the same test set (Figure 2.7). So it is
more reasonable for the algorithm to train a classifier for a given ratio of partial-length
mRNAs within training set as well as introduce the mathematical model of partial-length
transcripts as mentioned in section Materials and Methods. To this end, we further designed
a majority voting strategy as follows. The LncADeep model was first trained on training
sets with various ratios of partial-length mRNAs. Herein we trained 21 classifiers, and each
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LncADeep (AUC = 99.71%)
CNCI (AUC = 93.36%)
CPAT (AUC = 98.88%)
CPC2 (AUC = 98.61%)
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COME (AUC = 99.20%)
PLEK (AUC = 99.48%)
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FEElnc (AUC = 99.31%)
lncRNA−MFDL (AUC = 98.60%)
lncRScan−SVM (AUC = 99.11%)
longdist (AUC = 69.47%)
Figure 2.5: Mean ROC curves for lncRNA identification with 10-fold cross-validation on
full-length human transcripts.
We plot the mean ROC curves for lncRNA identification by LncADeep and other tools with 10-
fold cross-validation on full-length human transcripts. Herein LncADeep achieves the highest
AUC of 99.71% and outperforms other tools, which is consistent with the results in Table 2.7.
from 100% to 0% both with a step of 5%. The details for construction of training sets for
the 21 classifiers can be referred to Figure 2.6. When using these 21 classifiers for lncRNA
identification, each classifier gives an output, then the decision will be voted by 21 outputs.
Our results showed that majority voting strategy overall outperformed a single classifier
trained on a specific ratio of partial-length mRNAs (Figure 2.7).
To evaluate the lncRNA identification performance of majority voting and various clas-
sifiers on transcripts including various compositions of full- and partial-length mRNAs, we
constructed various test datasets by randomly combining full- and partial-length mRNAs,
where full- and partial-length mRNAs are from the remaining test dataset of every rotation
(Figure 2.6), namely, the test dataset had no overlap with training dataset. In Figure 2.7, the
legend refers to the classifier trained on transcripts including a specific composition of full-
and partial-length mRNAs. For example, Classifier 30 70 represents the classifier trained
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randomly sample 3,322 mixed-length mRNAs randomly sample 29,902 mixed-length mRNAs
GENCODE mRNAs (91,752)
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Figure 2.6: The construction of training and test sets for human transcripts with various
compositions of full- and partial-length mRNAs.
on transcripts including 30% full-length mRNAs and 70% partial-length mRNAs (the per-
centage is calculated within the mRNAs). As we can see, various classifiers show differ-
ent performance on various test datasets, demonstrating that the composition of full- and
partial-length mRNAs in training dataset can affect the lncRNA identification performance
on the test dataset. For instance, Classifier 0 100 outperformed other classifiers except
majority voting on the test dataset with mRNAs composition of 0(full) 100(partial)%, but
performed the worst on the test dataset with mRNAs composition of 100(full) 0(partial)%,
suggesting that it is not appropriate to use an arbitrary classifier for lncRNA identifica-
tion in real dataset. In contrast, majority voting consistently outperformed other classi-
fiers, except for the test datasets with mRNA compositions of 95(full) 5(partial)% and
100(full) 0(partial)%. However, the Classifiers 100 0 and 95 5 that outperformed major-
ity voting (on test datasets with mRNAs compositions of 95 5% and 100 5%) performed
poorly on the other compositions (compared with majority voting). To keep the generaliza-
tion performance, it would be better to use majority voting for test dataset whose compo-
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sition of full- and partial-length mRNAs is unknown. For the test dataset that is composed
of full-length transcripts, we recommend using the model designed for full-length tran-
scripts. Results showed that majority voting overall outperformed a single classifier that
was trained on a specific composition of full- and partial-length mRNAs, demonstrating its
effectiveness (Figure 2.7).
Table 2.8: Comparison of performances for lncRNA identification with 10-fold cross-
validation on full- and partial-length human transcripts.
Tool
Full- and partial-length transcriptsa
Full- and partial-lengthb Partial-length
Sn (%) Sp (%) Hm (%) Sn (%) Sp (%) Hm (%)
COME 86.9±0.6 97.2±0.3 91.8±0.3 86.9±0.6 96.1±0.4 91.2±0.3
lncScore 93.7±0.6 89.7±0.6 91.6±0.3 93.7±0.6 83.5±0.5 88.3±0.4
lncRScan-SVM 81.8±0.8 94.9±0.4 87.9±0.4 81.8±0.8 91.6±0.3 86.4±0.5
CPC 98.9±0.1 69.0±0.4 81.3±0.3 98.9±0.1 57.5±0.3 72.7±0.3
CNCI 97.3±0.2 79.3±0.7 87.4±0.5 97.3±0.2 70.1±0.6 81.5±0.4
CPAT 89.8±0.7 88.0±0.4 88.9±0.5 89.8±0.7 80.6±0.6 85.0±0.6
CPC2 94.4±0.5 70.1±0.4 80.4±0.4 94.4±0.5 52.5±0.4 67.5±0.4
FEElnc 92.5±0.4 91.1±0.7 91.8±0.4 92.5±0.4 86.1±0.7 89.2±0.5
PLEK 98.1±0.2 70.2±0.7 81.8±0.4 98.1±0.2 55.1±0.3 70.5±0.2
longdist 98.6±0.2 51.4±0.2 67.6±0.2 98.6±0.2 55.1±0.2 70.7±0.2
lncRNA-MFDL 93.9±0.4 80.8±0.4 86.9±0.3 93.9±0.4 69.4±0.6 79.8±0.5
LncADeep 93.8±0.5 94.5±0.4 94.2±0.3 93.8±0.5 90.3±0.6 92.0±0.5
a The dataset is from GENCODE (lncRNAs and full- and partial-length mRNAs). LncADeep was trained
for the model targeting transcripts including full- and partial-length.
b The composition of mRNAs in test set is 65% full-length and 35% partial-length, which matches the
composition of full- and partial-length mRNAs in GENCODE dataset.
We thus compared the 10-fold cross-validation performances of LncADeep and other
tools on transcripts including full- and partial-length. The results were listed in Table
2.8, where two test sets were used, one including both full-length and partial-length mR-
NAs whose composition (65 %full-length and 35% partial-length mRNAs) matches that
of GENCODE dataset, and the other including only partial-length mRNAs (Figure 2.6).
On the full- and partial-length test set, LncADeep achieves the highest harmonic mean of
94.2% with a noticeable advantage than others. Compared with the results for the full-
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length test set, the performance of all tools on partial-length test set were seen brought
down, clearly caused by the complication of partial-length transcripts. Among all the tools,
LncADeep achieves the highest harmonic mean of 92.0% on partial-length test set. Al-
though CPC has the highest sensitivity of 98.9% higher than LncADeep’s 93.8%, CPC
presents a much lower specificity of 57.5%. Meanwhile, the COME tool achieves the high-
est specificity of 96.1% higher than LncADeep’s 90.3%, but it does a much lower sensitivity
of 86.9%, leading to a harmonic mean of 91.2% lower than LncADeep’s 92.0%. Despite
achieving a comparable performance with LncADeep on partial-length test set, COME re-
lies on experimental information and reference genome annotation, while LncADeep is an
ab initio method which does not require these information and still outperforms COME.
Besides, we plotted the mean ROC curves for lncRNA identification by LncADeep and
other tools with 10-fold cross-validation on full- and partial-length human transcripts (Fig-
ures 2.8 and 2.9), and LncADeep achieved the highest AUC and outperformed other tools,
which complied with the results in Table 2.8. Furthermore, we constructed various test
sets by randomly combining full- and partial-length mRNAs (Figure 2.6) and compared
the performance of LncADeep and other tools on them. Figure 2.10 illustrated five tools,
LncADeep, COME, CPAT, FEElnc and lncScore with the best performances, while Figure
2.11 displayed the comparison for all tools. It is clear that the LncADeep tool outperforms
all other tools consistently no matter how the ratio of partial-length mRNAs varies.
In summary, with a series of cross-validation tests both for full-length transcripts and
partial-length transcripts, we show that the identification performance of LncADeep is
higher than all other tools, even with the over-estimation for several of them trained by
data overlapped with test sets.
2.3.2 Performance of lncRNA cross-species identification
In view of genetic conservation and diversity, it is worth expecting that the lncRNA pre-
dictors can be applied well in cross-species. To this end, we present the performance of
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Sn (%) Sp (%) Hm (%)
Reference-based
COME 98.4 41.1 58.0
lncScore 93.5 92.4 92.9
Reference-free
CPC 98.6 73.3 84.1
CNCI 96.2 85.5 90.6
CPAT 94.9 92.0 93.4
CPC2 93.9 89.7 91.8
FEElnc 94.8 92.7 93.7
PLEK 90.2 75.5 82.2
longdist 97.6 33.5 49.9
lncRNA-MFDL 95.9 91.7 93.8
LncADeep 97.0 96.3 96.7
a Full-length mouse dataset is composed of 12,529 lncRNAs (from GENCODE) and 29,739 mRNAs (from
RefSeq).
lncRNA cross-species identification by LncADeep and other tools, with their algorithms
trained on human data. Herein we chose the mouse for cross-species identification, as
mouse is evolutionarily close to human, and moreover there are relatively abundant exper-
imentally verified lncRNAs and mRNAs for mouse. As lncRScan-SVM cannot be used
for cross-species identification, we did not include it. We first performed the test against
the data for full-length transcripts, the results are shown in Table 2.9. LncADeep kept
high accuracy (with harmonic mean of 96.7%) on lncRNA cross-species identification on
full-length transcripts (Table 2.9). The harmonic mean of COME [102], CPC [69] and
PLEK [71] dropped to less than 90%, while other tools remained above. Besides, we plot-
ted the ROC curves as Figure 2.12, and LncADeep achieved the highest AUC of 99.61%
and outperformed other tools, which conformed with the results in Table 2.9. Moreover,
the specificity and harmonic mean of COME [102] dropped to less than 60%, which are
rather lower than its performance on human dataset, indicating that COME might not be
suitable for lncRNA cross-species identification. This might be COME is highly depen-
dent on the experimental information and reference genome annotation, which might not
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Table 2.10: Comparison of performances for cross-species lncRNA identification on full-
and partial-length mouse transcripts.
Tool
Full- and partial-length transcriptsa
Full- and partial-lengthb Partial-length
Sn (%) Sp (%) Hm (%) Sn (%) Sp (%) Hm (%)
COME 98.4 51.8 67.9 98.4 46.5 63.1
lncScore 93.5 90.9 92.1 93.5 83.6 88.2
CPC 98.6 70.0 81.9 98.6 56.0 71.5
CNCI 96.2 81.1 88.0 96.2 69.3 80.6
CPAT 89.9 90.4 90.2 89.9 82.0 85.8
CPC2 93.9 73.2 82.3 93.9 52.3 67.2
FEElnc 90.7 91.1 90.9 90.7 84.1 87.3
PLEK 90.2 66.3 76.4 90.2 50.5 64.8
longdist 97.6 47.9 64.2 97.6 54.8 70.2
lncRNA-MFDL 95.9 89.4 92.6 95.9 77.6 85.8
LncADeep 95.1 93.3 94.2 95.1 87.7 91.2
a Full- and partial-length mouse dataset is composed of 12,529 lncRNAs (from GENCODE) and 56,744
mRNAs (39,079 full-length and 17,665 partial-length, from GENCODE).
b The composition of mRNAs in test set is 70% full-length and 30% partial-length, which matches the
composition of full- and partial-length mRNAs in GENCODE dataset.
be conservative across species.
In addition, we conducted cross-species lncRNA identification for mouse transcripts
including full- and partial-length (Table 2.10 and Figures 2.13 and 2.14), LncADeep still
achieved highest specificity (93.3%) and harmonic mean (94.2%). To comprehensively
measure the performance of cross-species lncRNA identification on transcripts including
full- and partial-length, we constructed various test sets by randomly combining full- and
partial-length mouse mRNAs, where the percentage of full-length mRNAs ranges from 0%
to 100% with a step of 5% (Figure 2.15). Figure 2.16 displayed the five tools with the
best performance on cross-species lncRNA identification (Figure 2.17 plotted all bench-
marked tools). Similar to Figure 2.10, LncADeep consistently outperformed other tools for
cross-species lncRNA identification on mouse datasets. To summarize, the above results
showed that LncADeep also outperformed state-of-the-art tools for cross-species lncRNA
identification on mouse transcripts including full- and partial-length.
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2.4 Discussion
For lncRNA identification, LncADeep has outperformed the state-of-the-art tools through
integrating sequence and homology features with DBN. In particular, we designed two
models, one targeting full-length transcripts and the other targeting transcripts including
full- and partial-length.
To our knowledge, LncADeep is the first tool using the EDP of ORF for lncRNA identi-
fication. For the model targeting full-length transcripts, we used ORF length and coverage,
the EDP of ORF, mean hexamer score, UTR coverage and GC content, Fickett nucleotide
feature, and HMMER index, where the dimension of the EDP of ORF accounts for over
two thirds. The success of LncADeep on lncRNA identification again supported the hy-
pothesis that protein-coding and noncoding ORFs have different distributions in the EDP
phase space, which can be caused by various selection pressure during evolution [117,
118]. Although most lncRNA identification tools can reach an accuracy over 90% on full-
length transcripts, LncADeep has achieved the highest one with 97.7%. Actually, a tiny
improvement of the accuracy matters: since there are a large number of lncRNAs (over
27,000 lncRNAs have been collected in GENCODE Release 24, and more are to be iden-
tified), one percent improvement on the accuracy indicates hundreds of correctly identified
lncRNAs. With the development of sequencing technology, the third-generation sequenc-
ing technologies are emerging and being prevalent. The length of reads (ranges from 8,000
to 20,000 nt) sequenced by the third-generation sequencing technologies [125, 126] suf-
fices for sequencing full-length transcripts, where LncADeep achieves high accuracy on
lncRNA identification.
Current lncRNA identification is mainly based on transcripts assembled from RNA-seq
data with the Next-generation sequencing technologies. Because of the length of short
reads, assembled transcripts tend to be composed of full- and partial-length, while partial-
length mRNAs can lead to partial CDS and complicate the identification of lncRNAs. For
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partial-length mRNAs containing only partial CDS, the LORF-based model targeting on
full-length transcripts can be error-prone. To address this problem, we modified the LORF-
based model by searching the LCDS, which is chosen from two candidate sequences, ORF-
based CDS and Hexamer-based CDS. For a partial-length mRNA, LCDS is more likely to
overlap with the true CDS region. Accurately identifying the CDSs of mRNAs can help
to avoid misclassifying mRNAs into lncRNAs. In this work, we use two strategies to
detect putative CDS from transcripts, including the longest ORF (LORF) for full-length
transcripts and the longest CDS (LCDS) for transcripts including full- and partial-length.
To evaluate the performance of these two strategies, we used LORF and LCDS to de-
tect CDSs on full- and partial-length mRNAs, and compared the detected CDSs with known
CDSs. The datasets were from GENCODE Release 24, including 58,528 full-length and
33,224 partial-length mRNAs of human, where the locations of CDSs are known. To quan-
tify the performance of detecting CDS using the above two strategies, we used Mutual








where Loverlap refers to the length of the overlapped sequence between known CDS and
detected CDS, Lknown refers to the length of known CDS, and Ldetected represents the length
of detected CDS. As Loverlap ≤ Lknown and Loverlap ≤ Ldetected, we have 0 ≤ MOR ≤ 1.
The higher MOR, the better detected CDS.
Figures 2.18 and 2.19 illustrated the MOR on full- and partial-length mRNAs respec-
tively. On full-length mRNAs (Figure 2.18), LCDS and LORF showed comparable per-
formance. However, on partial-length mRNAs (Figure 2.19), LCDS outperformed LORF
significantly. Therefore, when the transcripts are of full-length, it is better to use LORF
strategy; when the transcripts are of full- and partial-length, it is more robust and much
better to use LCDS strategy.
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The reasons why LCDS performs better than LORF on partial-length transcripts might
be, LORF is highly dependent on searching start and stop codons, but for partial-length
transcript, the start and stop codons for true CDS might be missed, which can bias the
locating of true CDS. As for LCDS, apart from locating LORF, it considers the Hexamer-
based CDS, which will not be affected even if the start and stop codons are missed.
To evaluate the performance of various features used in the model for transcripts includ-
ing full- and partial-length, we divided the features into three groups, i.e., LCDS-related
features (including The EDP of the LCDS, the length and coverage of the LCDS, and Mean
Hexamer Score, as these features are dependent on the LCDS), Fickett nucleotide feature,
and HMMER index. Then, we conducted 10-fold cross-validation with these individual
groups of features. Tables 2.11 and 2.12 displayed the performance of individual group of
features in lncRNA identification. The datasets were human transcripts from GENCODE
v24. When identifying lncRNAs from full-length transcripts, the LCDS-related features
achieve the highest sensitivity, specificity, and harmonic mean, which is clearly higher than
that of Fickett and HMMER features. For partial-length transcripts, LCDS-related features
still showed highest performance with the average harmonic mean of 89.9%, which is 9.9%
and 6.2% higher than that of Fickett and HMMER features, respectively. The performance
comparison demonstrates the discriminative power of distinguishing lncRNAs from mR-
NAs using LCDS-related features.
Table 2.11: The performance of various features in lncRNA identification (only full-length
mRNAs)
Features Sn (%) Sp (%) Hm (%)




HMMER index 95.4±0.3 84.5±0.6 89.6±0.3
	
In real dataset, the composition of full- and partial-length mRNAs is unknown, then
it is not appropriate to train a specific classifier for any given real dataset. In this pa-
per, we proposed to use majority voting, and results have shown the effectiveness of our
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Table 2.12: The performance of various features in lncRNA identification (only partial-length
mRNAs)
Features Sn (%) Sp (%) Hm (%)




HMMER index 95.4±0.3 74.5±0.6 83.7±0.4
	
strategy (Figures 2.10 and 2.16). Apart from using majority voting, we tested LncADeep
on transcripts including various compositions of full- and partial-length mRNAs without
majority voting, that is, we used all the negative training dataset (full- and partial-length
mRNAs) for training. As illustrated in Figure 2.20, even if we do not use majority voting,
LncADeep still showed overall better performance than other tools, indicating LncADeep’s
advantages. Although CNCI, lncScore and FEElnc also realized the partial-length mRNAs
in real datasets, they did not address the various compositions of full- and partial-length
mRNAs. To our knowledge, LncADeep is the first tool addressing this problem in real
dataset and outperforms state-of-the-art tools.
As aforementioned, lncRNA identification methods can be divided into two groups,
reference-based and reference-free methods. Reference-based tools which require the ref-
erence genome information (e.g, exon number) of transcript for lncRNA identification (e.g.,
lncScore [104], lncRScan-SVM [72]) might suffer some ambiguities for novel transcripts
with alternative splicing structures. As for COME [102], which requires additional ex-
perimental information, it might not be suitable for cross-species lncRNA identification
(Table 2.9). In contrast, LncADeep belongs to reference-free (or ab initio) methods, and
one immediate advantage is: for non-model organisms without comprehensive genome
annotation, LncADeep can still be used for lncRNA identification. Tables 2.9 and 2.10
have shown LncADeep’s high performance on cross-species lncRNA identification. When
conducting cross-species lncRNA identification, it is recommended that LncADeep be used
for evolutionarily-close species. Currently, we have released models for human and mouse,
and plan to train additional models for more model organisms.
50
To benchmark the time cost for lncRNA identification tools, we randomly selected 1000
transcripts, and tested tools on the same machine (3.6 GHz quad-core Intel i7-4790 proces-
sors, 24 GB memory, Ubuntu 16.04) and measured the elapsed (wall clock) time. We
did not include reference-based tools, because these tools ignore the time cost for align-
ing transcripts to reference genome, which overestimates their efficiency. Benchmarked
on 1,000 randomly chosen transcripts, the time cost of each tool was as following: CNCI
(11 minutes), CPAT (2 seconds), CPC (1963 minutes), CPC2 (2 seconds), FEElnc (57
minutes), lncRNA-MFDL (143 minutes), longdist (5 seconds), PLEK (22 seconds), and
LncADeep (9 minutes). CPAT, CPC2, longdist and PLEK were ranked as the fastest tools.
This is reasonable as CPAT, CPC2, longdist and PLEK are alignment-free tools and only
need to extract features by computing occurrences of kmers. Even though LncADeep re-
quires aligning transcripts to Pfam database, LncADeep was as fast as CNCI, and faster
than FEElnc, lncRNA-MFDL, and CPC. In a few words, the time cost of LncADeep was
competitive among state-of-the-art tools.
2.5 Conclusions
With deep learning, we presented a novel ab initio lncRNA identification tool LncADeep
based on deep belief network. Specifically, we designed models targeting full-length tran-
scripts and transcripts including full- and partial-length. With the development of high-
throughput sequencing technologies, the third-generation sequencing technologies, such as
PacBio [125] and Nanopore [126], can generate full-length transcripts and are becoming
prevalent. The accuracy of lncRNA identification of LncADeep reached up to 97.7% on
full-length transcripts, which will be helpful for identifying novel lncRNAs from dataset
generated by third-generation sequencing technologies. Meanwhile, current research on
lncRNAs is mainly based on the Next-generation sequencing technologies, which tend
to produce reads of short length, impeding the reconstruction of full-length transcripts,
which in turn complicate the identification of lncRNAs. To address this problem, we pro-
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posed LCDS-based model to describe partial-length transcripts. In addition, considering
various compositions of full- and partial-length transcripts in real datasets, we integrated
majority voting strategy. With a comprehensive performance comparison between our pro-
gram LncADeep and other tools, results showed that LncADeep achieved better perfor-
mance than state-of-the-art tools, including CPC, CPC2, CPAT, CNCI, COME, lncRScan-
SVM, longdist, lncRNA-MFDL, lncScore, FEElnc and PLEK. Moreover, as a reference-
free (or ab initio) tool, LncADeep does not require any reference genome annotation, and
still outperformed other tools on cross-species lncRNA identification. It is expected that
LncADeep can contribute on accurately identifying lncRNAs for RNA-seq community, and
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Figure 2.7: The lncRNA identification performance of majority voting and various classi-
fiers on human transcripts.
To evaluate the lncRNA identification performance of majority voting and various classifiers on
transcripts including various compositions of full- and partial-length mRNAs, we constructed var-
ious test datasets by randomly combining full- and partial-length mRNAs, where full- and partial-
length mRNAs are from the remaining test dataset of every rotation (Figure 2.6), namely, the
test dataset had no overlap with training dataset. The legend refers to the classifier trained on tran-
scripts including a specific composition of full- and partial-length mRNAs. For example, Classifier
30 70 represents the classifier trained on transcripts including 30% full-length mRNAs and 70%
partial-length mRNAs (the percentage is calculated within the mRNAs). As we can see, various
classifiers show different performance on various test datasets, demonstrating that the composition
of full- and partial-length mRNAs in training dataset can affect the lncRNA identification perfor-
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LncADeep (AUC = 98.55%)
CNCI (AUC = 86.36%)
CPAT (AUC = 90.96%)
CPC2 (AUC = 89.71%)
CPC (AUC = 94.79%)
COME (AUC = 97.30%)
PLEK (AUC = 92.46%)
lncScore (AUC = 97.09%)
FEElnc (AUC = 97.36%)
lncRNA−MFDL (AUC = 93.02%)
lncRScan−SVM (AUC = 96.87%)
longdist (AUC = 77.28%)
Figure 2.8: Mean ROC curves for lncRNA identification with 10-fold cross-validation on
full- and partial-length human transcripts.
We plot the mean ROC curves for lncRNA identification by LncADeep and other tools with 10-fold
cross-validation on full- and partial-length human transcripts, where the composition of mRNAs
in test set is 65% full-length and 35% partial-length, which matches the composition of full- and
partial-length mRNAs in GENCODE dataset. Herein, LncADeep achieves the highest AUC of
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LncADeep (AUC = 97.29%)
CNCI (AUC = 78.60%)
CPAT (AUC = 87.80%)
CPC2 (AUC = 77.79%)
CPC (AUC = 90.40%)
COME (AUC = 96.79%)
PLEK (AUC = 83.86%)
lncScore (AUC = 95.16%)
FEElnc (AUC = 95.77%)
lncRNA−MFDL (AUC = 86.10%)
lncRScan−SVM (AUC = 95.03%)
longdist (AUC = 81.22%)
Figure 2.9: Mean ROC curves for lncRNA identification with 10-fold cross-validation on
partial-length human transcripts.
We plot the mean ROC curves for lncRNA identification by LncADeep and other tools with 10-
fold cross-validation on partial-length human transcripts, where the composition of mRNAs in test
set is only partial-length. Herein, LncADeep achieves the highest AUC of 97.29% and outperforms
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Figure 2.10: The performance of lncRNA identification on human transcripts with various
compositions of full- and partial-length mRNAs.
LncADeep outperforms all other tools consistently no matter how the ratio of partial-length mR-
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Figure 2.11: The performance of lncRNA identification on human transcripts with various
compositions of full- and partial-length mRNAs.
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LncADeep (AUC = 99.61%)
CNCI (AUC = 94.78%)
CPAT (AUC = 98.89%)
CPC2 (AUC = 98.62%)
CPC (AUC = 98.49%)
COME (AUC = 88.94%)
PLEK (AUC = 95.37%)
lncScore (AUC = 98.82%)
FEElnc (AUC = 98.86%)
lncRNA−MFDL (AUC = 98.96%)
longdist (AUC = 73.70%)
Figure 2.12: ROC curves for cross-species lncRNA identification on full-length mouse
transcripts.
We plot ROC curves for cross-species lncRNA identification by LncADeep and other tools on
full-length mouse transcripts. Herein, LncADeep achieves the highest AUC of 99.61% and out-
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LncADeep (AUC = 98.63%)
CNCI (AUC = 89.59%)
CPAT (AUC = 96.70%)
CPC2 (AUC = 91.74%)
CPC (AUC = 95.72%)
COME (AUC = 89.23%)
PLEK (AUC = 86.23%)
lncScore (AUC = 97.75%)
FEElnc (AUC = 97.19%)
lncRNA−MFDL (AUC = 97.66%)
longdist (AUC = 78.07%)
Figure 2.13: ROC curves for cross-species lncRNA identification on full- and partial-length
mouse transcripts.
We plot ROC curves for cross-species lncRNA identification by LncADeep and other tools on full-
and partial-length mouse transcripts, where the composition of mRNAs in test set is 70% full-
length and 30% partial-length, which matches the composition of full- and partial-length mRNAs
in GENCODE dataset. Herein, LncADeep achieves the highest AUC of 98.63% and outperforms
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LncADeep (AUC = 97.56%)
CNCI (AUC = 81.31%)
CPAT (AUC = 93.35%)
CPC2 (AUC = 79.06%)
CPC (AUC = 91.44%)
COME (AUC = 84.04%)
PLEK (AUC = 70.96%)
lncScore (AUC = 95.92%)
FEElnc (AUC = 95.11%)
lncRNA−MFDL (AUC = 94.01%)
longdist (AUC = 84.02%)
Figure 2.14: ROC curves for cross-species lncRNA identification on partial-length mouse
transcripts.
We plot the ROC curves for cross-species lncRNA identification by LncADeep and other tools
on partial-length mouse transcripts, where the composition of mRNAs in test set is only partial-
length. Herein, LncADeep achieves the highest AUC of 97.56% and outperforms other tools,
which is consistent with the results in Table 2.10.
randomly sample 17,665 mixed-length mRNAs
GENCODE mRNAs (56,744)
Full-length (39,079) Partial-length (17,665)
X% full-length (100 - X)% partial-length
X ranges from 0 to 100, with a step of 5
21 test sets
GENCODE lncRNAs (12,529)
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Figure 2.16: The performance of cross-species lncRNA identification on mouse transcripts
with various compositions of full- and partial-length mRNAs.
LncADeep outperforms all other tools consistently for cross-species lncRNA identification on
mouse datasets no matter how the ratio of partial-length mRNAs varies. This figure illustrates five
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Figure 2.17: The performance of cross-species lncRNA identification on mouse transcripts
with various compositions of full- and partial-length mRNAs.
LncADeep outperforms all other tools consistently for cross-species lncRNA identification on
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Figure 2.18: The Mutual Overlap Rate on full-length mRNAs.
Mutual Overlap Rate (MOR) quantify the performance of detecting CDS. On full-length mRNAs,
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Figure 2.19: The Mutual Overlap Rate on partial-length mRNAs.
Mutual Overlap Rate (MOR) quantify the performance of detecting CDS. On partial-length mR-
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LncADeep (without Majority Voting)
LncADeep (with Majority Voting)
Figure 2.20: The lncRNA identification performance on human transcripts (with and with-
out majority voting).
Apart from using majority voting, we tested LncADeep on transcripts including various composi-
tions of full- and partial-length mRNAs without majority voting, that is, we used all the negative
training dataset (full- and partial-length mRNAs) for training. As we can see in this figure, even
without Majority Voting, LncADeep still showed overall better performance than other four tools,
while LncADeep with majority voting showed highest performance. Here, only the five tools with
the best performance were plotted.
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CHAPTER 3
PREDICT LNCRNA-PROTEIN INTERACTIONS AND INFER LNCRNA
FUNCTIONS
This chapter describes the method we proposed for predicting lncRNA-protein interactions
based on a deep learning algorithm. The predicted interacting proteins are then used for in-
ferring the functions of lncRNAs. The proposed method for predicting lncRNA-protein
interaction and inferring lncRNA functions has been implemented into the tool named
LncADeep (http://cqb.pku.edu.cn/ZhuLab/LncADeep).
3.1 Introduction
After identifying lncRNAs, the next step is to infer their functions. However, compre-
hensively characterizing lncRNAs is not simple since the functions of lncRNAs tend to
be “diverse and complex” [85]. To exert biological functions, lncRNAs can interact with
DNAs, RNAs, and proteins (lncRNA-protein interactions), and protein is confirmed to be
the first and principle partner of lncRNAs [60, 50, 61]. Among the three categories of
interactions, the interactions between lncRNAs and DNAs/RNAs are less studied, while
lncRNA-protein interactions play the crucial roles in the functioning of lncRNA, providing
satisfactory details of how lncRNAs exert functions in various biological processes [60].
For example, lncRNA HOTAIR can interact with polycomb repressive complex 2 (PRC2)
and the CoREST-LSD1 complex to “specify the pattern of histone modification on target
genes” [55]. Interacting with 81 proteins from chromatin modification, nuclear matrix and
RNA remodeling pathways, Xist is an essential lncRNA for X chromosome inactivation
[56]. Thus, identifying lncRNA-protein interactions will contribute to the understanding of
lncRNA functions and mechanisms in biological process.
Although several experimental approaches, such as cross-linking and immunoprecipita-
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catRAPID Non-linear Discriminate No Yes 2011
GlobalScore Non-linear Discriminate No Yes 2017





RPI-Pred SVM Yes Yes 2015
rpiCool Random Forest Yes No 2016
IPMiner Deep neural network Yes No 2016
	
tion (CLIP) [127] and chromatin isolation by RNA purification (ChIRP) [78], are available
for probing RNA-protein interactions, experimental approaches are expensive and time-
consuming [106, 128]. In contrast, computational approaches are more convenient and
rapid, and can employ experimentally verified datasets to infer lncRNA-protein interac-
tions. Therefore, it is essential to develop computational approaches to predict lncRNA-
protein interaction. Several methods are available (Table 3.1), such as catRAPID [129],
GlobalScore [130], RPISeq [106], lncPro [86], RPI-Pred [107], rpiCool [108], and IPMiner
[109], and these methods do not rely on the interaction networks among lncRNAs and pro-
teins. They integrate sequence and/or structure features of RNAs and proteins to predict
interactions (Table 3.1). catRAPID, GlobalScore and lncPro combine secondary structure,
hydrogen-bonding and Van der Waals propensities; RPISeq, rpiCool, and IPMiner use k-
mer based sequence information; RPI-Pred employs both k-mer based sequence features
and predicted structure features of proteins and RNAs. To construct models, most of these
tools use machine learning algorithms, such as SVM (RPISeq and RPI-pred), Random
Forests (RPISeq and rpiCool), Linear Discriminate Method (lncPro) and stacked ensem-
bling of neural network (IPMiner). A very recently developed tool, IPMiner, constructs a
complicated model: first, it employs stacked autoencoder to extract hidden features from
k-mer based sequence information; second, these features are fed to random forest models;
and finally, stacked ensembling of neural networks are used to improve the prediction per-
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formance [109]. However, these methods do not give functional annotations for lncRNAs,
except outputting the interaction results.
LPIHN [131], [132], and LPBNI [133] are interaction network-based methods, which
requires known information to construct interaction network for predicting potential inter-
actions in the network. LPINH needs known protein-protein interactions, lncRNAs ex-
pression similarity, and known lncRNA-protein interactions to construct a heterogeneous
network, and then infers lncRNA-protein interactions with random walk. Similarly, [132]
constructs a heterogeneous lncRNA-protein network, but adopts a relevance search algo-
rithm for interaction prediction. LPBNI requires known lncRNA-protein interactions to
build a lncRNA-protein bipartite network, and then applies a propagation method to com-
pute the interaction score. However, these network-based methods are highly dependent
on known information and can predict only potential novel interactions in the network. For
many lncRNAs whose lncRNA-protein interactions and lncRNA-lncRNA similarity are un-
known, the interaction network cannot be constructed and the potential interactions cannot
be inferred. Besides, the lacking of executive tools limits the application of LPBNI, [132],
and LPIHN. Therefore, in this dissertation, we focus on network-independent methods.
For lncRNA functional annotation, we infer the functions of a lncRNA from its interact-
ing proteins. Here, LncADeep adopts deep neural networks for predicting lncRNA-protein
interaction using both sequence and structure information, achieving better performance
compared with RPISeq, RPI-pred, rpiCool, IPMiner and lncPro. Then, LncADeep in-
tegrates KEGG [134] and Reactome [135] pathway enrichment analysis and functional
module detection with the predicted interacting proteins. Thus, LncADeep provides the
over-represented KEGG and Reactome pathways and functional modules as functional an-
notations for lncRNAs. As an ab initio lncRNA functional annotation tool, we expect that
not only can LncADeep predict the interacting proteins of lncRNAs, but also provide help-
ful functional annotations for lncRNAs.
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3.2 Materials and methods
3.2.1 Data description
To predict lncRNA-protein interactions, we obtained data from NPInter database [136],
which collects experimentally verified lncRNA-protein interacting pairs. Since we focus on
human lncRNA-protein interactions, we kept only the interacting pairs labeled with ‘Homo
sapiens’ and ‘ncRNA-protein binding’, and removed the interacting pairs whose ncRNA is
shorter than 200 nt. After removing redundant and obsolete interacting pairs (some lncR-
NAs were removed in the latest version of NONCODE, we filtered these lncRNA-related
pairs), we finally obtained 6,204 lncRNA-protein interacting pairs consisting of 2,356 lncR-
NAs and 90 proteins. The sequences of lncRNAs and proteins were from NONCODE [137]
and Uniprot [138] respectively. As NPInter provides only interacting lncRNA-protein pairs,
which are considered as positive class, we need to generate non-interacting lncRNA-protein
pairs as negative class. To construct a balanced negative dataset, we referred to the method
used in [108, 106], i.e., pair lncRNAs and proteins, exclude all known interactions, and
randomly keep 6,204 lncRNA-protein pairs as non-interacting ones.
3.2.2 Methods
To characterize lncRNA-protein interacting pairs, we use both sequence and structure in-
formation, which have been shown useful in [108, 106, 107]. The flowchart of predicting
lncRNA-protein interaction is illustrated in Figure 3.1. For sequence information, each




























Figure 3.1: The flowchart of predicting lncRNA-protein interaction.
We use sequence and structure features for the prediction of lncRNA-protein interaction. X1, X
′
1
and X2 refer to sequence features, sequence features after feature selection, and structure features,
respectively. The identified lncRNAs can be input for predicting lncRNA-protein interactions, then
the interacting proteins can be used for inferring the functions of lncRNAs.
where H = −
∑256
j=1 cj log cj is the Shannon entropy, cj is the abundance of jth 4-mer, and
i, j = 1, . . . , 256 represents the index of the 256 4-mers.
Apart from the EDP of 4-mer, we encode a lncRNA with the features used in lncRNA
identification, including Fickett nucleotide feature and the features of LCDS (i.e., the EDP
of the LCDS, LCDS length and coverage, and Mean hexamer score), which consists of a
47-dimensional vector.
Proteins are represented using conjoint triad method proposed in [139]. First, the 20
amino acids are divided into seven groups according to their dipole moments and side chain
volume: {A, G, V}, {I, L, F, P}, {Y, M, T, S}, {H, N, Q, W}, {R, K}, {D, E}, and {C}.
Then, each protein sequence is encoded with a 343-dimensional vector, which is the EDP




pi log pi (3.2)
where H = −
∑343
j=1 pj log pj is the Shannon entropy, pj is the abundance of jth 3-mer, and
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i, j = 1, . . . , 343 represents the index of the 343 3-mers.
In total, each lncRNA-protein pair is represented by a 646 (44 + 73 + 47 = 646) dimen-
sional sequence feature vector. However, that many features can incur overfitting when
the size of training data is relatively small, while the number of experimentally verified
lncRNA-protein interacting pairs is limited (only 6204 interacting pairs are available). To
alleviate overfitting, one approach is to use only the most discriminative features for model
training [140]. Thus, we conduct feature selection with mRMR (minimal-redundancy-
maximal-relevance criterion) [141]. As a feature selection method based on mutual in-
formation, mRMR can select a list of most characterizing features from candidate ones
[141]. We tried selecting 100 features (the average 5-fold cross-validation harmonic mean
was 90.7%) and 110 features (the average 5-fold cross-validation harmonic mean was
90.8%) using mRMR. Since the average 5-fold cross-validation accuracy of 110 features
was higher, we chose to select 110 features. The detailed parameters for mRMR are list in
Table 3.2.
For structure information, we use the structure features of lncRNA and protein, includ-
ing secondary structure, hydrogen-bonding and Van der Waals propensities [86]. To predict
the secondary structure of a lncRNA, we use RNAfold [113]. However, RNAfold can be
very time consuming as its time complexity is O(L3), where L is the length of sequence.
To address this problem, we use a naive segmentation method to segment lncRNA se-
quence before predicting its secondary structure, since sequence segmentation can enhance
the prediction accuracy and decrease the time cost [142]. To choose a segment length for
Table 3.2: The parameters of mRMR
Options Value
-t [threshold] 0.2
-n [number of features] 110
-s [MAX number of samples] 12408







100 150 200 250 300 350


































Figure 3.2: The average 5-fold cross-validation accuracy of predicting lncRNA-protein
interaction.
To choose a segment length for lncRNA, we evaluated the performance of various segment lengths
(ranging from 100 nt to 350 nt with a step of 50 nt) on predicting lncRNA-protein interaction. This
figure displayed the average 5-fold cross-validation harmonic mean of various segment lengths.
Considering the balance between the time cost (please refer to https://www.tbi.univie.ac.at/RNA/)
and the accuracy, we chose n = 250 to segment lncRNA for secondary structure prediction.
lncRNA, we evaluated the performance of various segment lengths (ranging from 100 nt to
350 nt with a step of 50 nt) on predicting lncRNA-protein interaction. Figure 3.2 displayed
the average 5-fold cross-validation accuracy of various segment lengths. Considering the
balance between the time cost (please refer to https://www.tbi.univie.ac.at/RNA/) and the
accuracy, we chose n = 250 to segment lncRNA for secondary structure prediction. First,
a lncRNA is segmented into fragments with at most n = 250nt; then RNAfold is used to
predict the secondary structure for each fragment; in the end, the secondary structure of
each fragment are concatenated as the secondary structure of the lncRNA.
For the other structure features, we follow the process mentioned in lncPro [86]. The
structure information of a lncRNA-protein pair is encoded using a 80-dimensional vector



































Figure 3.3: The structure of DNN for predicting lncRNA-protein interaction.
(a) The first step is to train two neural networks using only sequence or structure features separately
and then output the prediction results. (b) The second step is to employ the prediction results from
(a) as additional features and concatenate them to sequence and structure features, and use both
sequence and structure features for training. (c) The third step is to use the prediction results
from (b) as additional features and concatenate them again to sequence and structure features.
Then another neural network will be trained with the features and output the prediction results.
The prediction results can then be concatenated to the features again for training which leads to a
stacking neural network.
3.2.3 Deep neural network
We construct a deep neural network (DNN) for predicting lncRNA-protein interaction.
Inspired by the deep stacking network proposed in [143], the DNN is built as follows
(Figure 3.3). First, we train two neural networks using sequence or structure informa-
tion separately, where we can obtain the prediction results from sequence and structure
Table 3.3: The dimensions of the structure feature vector
Type Secondary structure Hydrogen-bonding Van der Waals
lncRNA 10-dimension 10-dimension 10-dimension
protein 10-dimension 20-dimension 20-dimension
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Table 3.4: The neural network architecture for sequence features
Layers Nodes
Input layer Sequence features (110 dim)
1st hidden layer Dense(30, input_dim=110)
2nd hidden layer Dense(20, activation='softmax')
Output layer: Dense(1, activation='sigmoid')







Van der Waals features
(30 dim)
1st hidden layer Dense(20, input_dim=20) Dense(30, input_dim=30) Dense(30, input_dim=30)
Merged layer 80 dim
1st hidden layer Dense(20, input_dim=80, activation='softmax')
2nd hidden layer Dense(10, activation='softmax')
Output layer Dense(1, activation='sigmoid')
Concatenate 
information (Tables 3.4 and 3.5). Second, the prediction results from the first step are
concatenated with the original sequence and structure features (as new features) to train
another neural network, where we can get prediction results using both sequence and struc-
ture information (Table 3.6). Third, the prediction results from the second step are again
concatenated with sequence and structure features to train another neural network, which
can be iterated several times (Table 3.7) The rationale is that the prediction results from
the previous step can offer additional helpful information. We use Keras 1.2.2 library
(https://github.com/fchollet/keras/) to implement the DNN.
3.2.4 Infer the functions of lncRNA
As NPInter provides only interacting lncRNA-protein pairs, we need to generate non-
interacting lncRNA-protein pairs as negative class. In this study, we follow the approach
used in several methods, such as RPISeq [106], rpiCool [108], and RPI-pred [107], i.e.,
pairing 2,356 lncRNAs and 90 proteins and removing known interacting lncRNA-protein
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Table 3.6: The neural network architecture for the second step
Layers Nodes
Input layer Sequence features (110 + 1 dim) Sturcture features (80 + 1 dim)
1st hidden layer Dense(30, input_dim=111) Dense(30, input_dim=81)
2nd hidden layer Dense(20, activation='softmax') Dense(20, activation='softmax')
Merged layer 40 dim
1st hidden layer Dense(20, activation='softmax'), Dropout(0.5)
2nd hidden layer Dense(20, activation='softmax'), Dropout(0.5)
3rd hidden layer Dense(10, activation='softmax'), Dropout(0.5)
Output layer Dense(1, activation='sigmoid')
Concatenate 
Table 3.7: The neural network architecture for the third step
Layers Nodes
Input layer Sequence features (111 + i dim) Sturcture features (81 + i dim)
1st hidden layer Dense(30, input_dim=111+i) Dense(30, input_dim=81+i)
2nd hidden layer Dense(20, activation='softmax') Dense(20, activation='softmax')
Merged layer 40 dim
1st hidden layer Dense(20, activation='softmax'), Dropout(0.5)
2nd hidden layer Dense(20, activation='softmax'), Dropout(0.5)
3rd hidden layer Dense(10, activation='softmax'), Dropout(0.5)
Output layer Dense(1, activation='sigmoid')
Concatenate 
pairs, and then we obtained 205,836 non-interacting pairs. However, 6,204 interacting pairs
and 205,836 non-interacting pairs led to a class-imbalance. To handle class-imbalance,
under-sampling the majority class is an efficient strategy, which is what we used for bench-
marking the lncRNA-protein interaction tools in the main text. However, when using the
trained model for predicting, it might suffer some drawbacks such as losing potential useful
data [144]. In the release version of LncADeep, to make full use of the non-interacting pairs
for predicting lncRNA-protein interactions, we use EasyEnsemble [144]. As a straightfor-
ward strategy to address the class-imbalance problem, EasyEnsemble [144] first indepen-
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dently samples several subsets from the majority class, then for each subset, a classifier
will be trained, and finally all classifiers will be combined for the final classification. In
this study, as the number of non-interacting pairs is around 33 times of that of interacting
pairs, first of all, we sampled 33 subsets from the non-interacting pairs. Second, for each
subset, we trained a classifier with the positive class (interacting pairs), and thus we obtain
33 classifiers and combine the results from 33 classifiers using majority voting. Finally, the
predicted interacting proteins are used for inferring the functions of lncRNAs.
To annotate the functions of a lncRNA from its predicted interacting proteins, LncADeep
integrates KEGG and Reactome pathway enrichment analysis and functional module de-
tection. Enrichment analysis is a prevalent approach to identify some over-represented
biological functions that shared by a group of genes or proteins based on statistical anal-
ysis, which can be referred to in [145]. To conduct KEGG and Reactome pathway en-
richment analyis, first, we downloaded reviewed human protein sequences from Uniprot
database [138], and finally obtained 20,121 protein sequences after filtering. Herein, we
filtered protein sequences whose length is shorter than 15 AA and longer than 15,000 AA,
as Predator [146] was used to predict the secondary structure of proteins and could not pro-
cess sequence whose length are not in that range. Then, LncADeep predicts the interacting
proteins of lncRNAs from the 20,121 proteins and conducts the function annotations with
the predicted interacting proteins. For KEGG and Reactome pathway enrichment analy-
sis, LncADeep uses Fisher’s exact test for the significance test, Benjamini-Hochberg (BH)
method [147] for the multiple testing correction, and keeps enriched pathways whose ad-
justed p-value is less than 0.05. Proteins usually function as modules, where protein-protein
interaction (PPI) information can be used for detecting functional modules [148], and inter-
preting the functional modules derived from the interacting proteins of lncRNAs can offer
some helpful information for the functions of lncRNAs. To detect functional modules in
the interacting proteins of a lncRNA, LncADeep uses Markov Clustering (MCL) [149] by
integrating PPI information provided by HIPPIE database [150], which collects experimen-
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tally verified interactions from various reliable sources. To display the functional modules,
we adopt iGraph (http://igraph.org/r/) [151] to plot their interacting networks.
3.2.5 Evaluation metrics
To evaluate the prediction performance of the LncADeep and other existing tools, we use
two independent quantities, Sn (sensitivity) and Sp (specificity), and a balanced quantity











where TP, TN, FP, and FN represents true positive, true negative, false positive, and false
negative respectively. Herein Sn measures the ratio of actual positives that are correctly
identified, Sp measures the ratio of true positives in all predicted positives, and Hm is
a composite measure of sensitivity and specificity [118]. For the prediction of lncRNA-
protein interaction, interacting lncRNA-protein pairs are regarded as positive class, and
non-interacting ones are as the negative.
3.3 Results
3.3.1 Performance of lncRNA-protein interaction prediction
To benchmark lncRNA-protein interaction prediction performance, we compared LncADeep
with lncPro [86], RPISeq [106], RPI-pred [107], rpiCool [108] and IPMiner [109], which
are state-of-the-art tools for predicting RNA-protein interactions, using 5-fold cross valida-
tion. Among these tools, IPMiner was the most recently developed and provides retraining
option. Thus, we retrained IPMiner, but for the others, we used the tools (lncPro and rpi-
Cool) or online servers (RPISeq and RPI-pred) as provided. Considering the unavailability
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of stand-alone tools of catRAPID [129] and GlobalScore [130], we tried to submit lncRNA-
protein pairs online and download the results, however, it was time-consuming and could
not be conducted in large scale. Therefore, we did not include catRAPID and GlobalScore
for benchmarking.
The harmonica mean of LncADeep reached up to 90.8%, outperforming the other five
tools (Table 3.8). Besides, we noted that the specificity and the harmonic mean of lncPro
[86], RPISeq [106] and RPI-pred [107] was much lower than that of rpiCool [108], IP-
Miner [109], and LncADeep, suggesting that lncPro, RPISeq and RPI-pred tend to pre-
dict most lncRNA-protein pairs as interacting ones. This might be the pre-built models of
lncPro, RPISeq, and RPI-pred were trained on datasets containing RNA-protein interacting
pairs, where the length of RNAs were much shorter than that of lncRNAs, thus limiting
the application of these methods on predicting lncRNA-protein interaction. Nevertheless,
LncADeep achieved better performance on the prediction of lncRNA-protein interaction
when compared with rpiCool and IPMiner.
3.3.2 Performance of lncRNA functional annotation
Accurate lncRNA-protein interactions can help to infer the functions of lncRNAs, we thus
used our tool LncADeep to annotate the functions for the 27,384 lncRNAs collected in
GENCODE Release 24. The functional annotations including KEGG and Reactome path-
Table 3.8: Comparison of performances for predicting lncRNA-protein interaction with
5-fold cross-validation.
Tools Sn(%) Sp(%) Hm(%)
lncPro 80.3±0.9 52.2±0.6 63.2±0.4
RPISeq (RF) 99.1±0.2 50.1±0.1 66.5±0.1
RPISeq (SVM) 93.5±0.7 50.2±0.2 65.3±0.4
RPI-pred 88.0±0.3 49.8±0.6 63.6±0.5
rpiCool 92.0±0.8 83.3±0.8 87.5±0.6
IPMiner 89.8±1.1 85.6±0.7 87.6±0.6
LncADeep 97.0±0.5 85.4±0.8 90.8±0.4
a RPISeq has two prediction modes, including SVM and random forest (RF).
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KEGG_path_ID KEGG_pathway p_value adj_p_value
PATH:ko05224 Breast cancer 0.00031 0.00799
PATH:ko04916 Melanogenesis 0.00099 0.00921
PATH:ko04390 Hippo signaling pathway 0.00109 0.00921
PATH:ko05217 Basal cell carcinoma 0.00142 0.00921
PATH:ko04610 Complement and coagulation cascades 0.00243 0.01261
PATH:ko04016 MAPK signaling pathway - plant 0.0068 0.02211
PATH:ko04512 ECM-receptor interaction 0.00522 0.02211
PATH:ko00910 Nitrogen metabolism 0.00638 0.02211
PATH:ko05150 Staphylococcus aureus infection 0.00951 0.02748
PATH:ko01210 2-Oxocarboxylic acid metabolism 0.01536 0.03995
PATH:ko01230 Biosynthesis of amino acids 0.01851 0.04293
PATH:ko04976 Bile secretion 0.02477 0.04293
PATH:ko00270 Cysteine and methionine metabolism 0.02047 0.04293
PATH:ko04310 Wnt signaling pathway 0.02201 0.04293
PATH:ko04066 HIF-1 signaling pathway 0.02466 0.04293
PATH:ko05014 Amyotrophic lateral sclerosis (ALS) 0.02693 0.04376
PATH:ko04011 MAPK signaling pathway - yeast 0.02911 0.04452
PATH:ko00190 Oxidative phosphorylation 0.03092 0.04466
PATH:ko04970 Salivary secretion 0.04037 0.04664
PATH:ko04971 Gastric acid secretion 0.04168 0.04664
PATH:ko04672 Intestinal immune network for IgA production 0.04267 0.04664
PATH:ko04150 mTOR signaling pathway 0.04306 0.04664
PATH:ko04260 Cardiac muscle contraction 0.03685 0.04664
PATH:ko04340 Hedgehog signaling pathway 0.03606 0.04664
PATH:ko04392 Hippo signaling pathway - multiple species 0.04878 0.04878
PATH:ko04933 AGE-RAGE signaling pathway in diabetic complications 0.04818 0.04878
Figure 3.4: An example of over-represented KEGG pathways.
This is an example of over-represented KEGG pathways for one alternative transcript of the
lncRNA HOTAIR.
ways and functional modules are provided as supplementary files that can be downloaded
online. Here, we focused on KEGG and Reactome pathways (Figure 3.4), which are
more explicit for annotating functions than functional modules (Figure 3.5). Consequently,
LncADeep annotated 702,675 associations with 140 KEGG pathways and 1,839,272 as-
sociations with 422 Reactome pathways for the 27,384 lncRNAs, with an average of 25
KEGG and 67 Reactome pathways associated with each lncRNA, conforming with the
complexity of lncRNA functions [60, 50, 61]. To our best knowledge, LncADeep is the
first tool that can automatically predict lncRNA-protein interactions and provide rich in-
ferred functional annotations for lncRNAs.
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Since IPMiner ranked next to LncADeep on lncRNA-protein interaction prediction, as
a comparison, we used IPMiner [109] (its release version) to predict interacting proteins
for 100 randomly sampled lncRNAs (IPMiner is very time-consuming and we cannot used
it for all the 27,384 lncRNAs, and thus we randomly sampled 100 lncRNAs) and then con-
ducted KEGG and Reactome pathway enrichment analysis with the predicted interacting
proteins. For these 100 randomly sampled lncRNAs, LncADeep annotated 2,555 asso-
ciations with 78 KEGG pathways and 6,697 associations with 216 Reactome pathways,
with an average of 25 KEGG and 67 Reactome pathways associated with each lncRNA,
matching the previous results. In contrast, using IPMiner-predicted interacting proteins,
we only obtained 473 associations with 37 KEGG pathways and 2,840 associations with
84 Reactome pathways, with an average of only 5 KEGG and 28 Reactome pathways as-
sociated with each lncRNA, which are much smaller than that of LncADeep, indicating
that LncADeep can give more detailed functional annotations for lncRNAs. In fact, as
LncADeep outperformed IPMiner on predicting lncRNA-protein interactions, LncADeep
is expected to provide better functional annotations. For lack of a gold standard dataset
for lncRNA functions, it is difficult to quantitatively evaluate the performance of inferred
functions of lncRNAs. Therefore, to demonstrate that LncADeep can provide helpful sug-
gestions on lncRNA functioning, we took four well-studied lncRNAs as examples through
comparing their inferred functions (by LncADeep and IPMiner) with the reported functions
from literatures.
3.3.3 Examples for lncRNA functional annotation
HOTAIR.
As an oncogenic factor and a potential biomarker for various cancers, HOTAIR has been
associated with several cancers [152], such as breast cancer [51] and cervical cancer [153],
and LncADeep’s annotations for HOTAIR comply with these known functions. First,
LncADeep associates HOTAIR with KEGG pathways such as PATH:ko05224 Breast can-
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cer, PATH:ko05200 Pathways in cancer, PATH:ko04330 Notch signaling pathway [153],
and PATH:ko04310 Wnt signaling pathway [154]. Second, LncADeep-predicted Reactome
pathways show that HOTAIR might be involved with R-HSA-1257604 PIP3 activates AKT
signaling [155], R-HSA-216083 Integrin cell surface interactions, and R-HSA-5628897
TP53 Regulates Metabolic Genes, which are related to cell adhesion, tissue and organ
morphogenesis, and cancers. LncADeep still outputs other enriched Reactome pathways.
In fact, the over-represented KEGG and Reactome pathways complement each other. In
contrast, using IPMiner-predicted interacting proteins, only two over-represented KEGG
pathways including PATH:ko05200 Pathways in cancer and PATH:ko04014 Ras signaling
pathway were detected, which cannot give detailed annotations for HOTAIR.
ANRIL.
ANRIL is involved in various human diseases, such as Melanoma [156], breast cancer
[157], basal cell carcinoma [158], and cardiovascular disease [159]. LncADeep-predicted
KEGG pathways for ANRIL conform with its known functions, namely PATH:ko05218
Melanoma, PATH:ko05224 Breast cancer, PATH:ko05217 Basal cell carcinoma, PATH:ko05200
Pathways in cancer, PATH:ko04260 Cardiac muscle contraction and PATH:ko04310 Wnt
signaling pathway [160]. As a contrast, using the predicted interacting proteins by IPMiner
for ANRIL, we obtained only three over-represented KEGG pathways, i.e., PATH:ko05200
Pathways in cancer, PATH:ko04015 Rap1 signaling pathway and PATH:ko04151 PI3K-
Akt signaling pathway. Compared with IPMiner, LncADeep can not only offer predicted
interacting proteins, but also give detailed annotation of ANRIL. Apart from the above dis-
eases, LncADeep still shows that ANRIL can be involved with some other diseases such as
PATH:ko05310 Asthma, PATH:ko05014 Amyotrophic lateral sclerosis, and PATH:ko05166
HTLV-I infection etc., which need further validation.
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SPRY4-IT1.
Derived from an intron of the SPRY4 gene situated at chromosome 5q31, SPRY4-IT1
has an important role in several tumors, such as melanoma [161] and breast cancer [162].
LncADeep predicts that SPRY4-IT1 can be involved in PATH:ko05224 Breast cancer,
PATH:ko04151 PI3K-Akt signaling pathway, PATH:ko05217 Basal cell carcinoma [163]
and PATH:ko04310 Wnt signaling pathway [164], which were also supported by the above
known functions. In contrast to LncADeep, IPMiner-predicted proteins can only give one
over-represented KEGG pathway (PATH:ko05200 Pathways in cancer).
TUNAR.
Located at chromosome 14q32, TUNAR lncRNA has been linked to human neurodegenera-
tive diseases [165], diabetes [166], and breast cancer [167]. LncADeep shows that TUNAR
is associated with PATH:ko05010 Alzheimer’s disease, PATH:ko05012 Parkinson’s dis-
ease, PATH:ko05014 Amyotrophic lateral sclerosis (ALS), PATH:ko05224 Breast cancer,
PATH:ko05200 Pathways in cancer and PATH:ko04933 AGE-RAGE signaling pathway in
diabetic complications, which comply with its known functions. Besides, PATH:ko04151
PI3K-Akt signaling pathway, PATH:ko04510 Focal adhesion, and PATH:ko04512 ECM-
receptor interaction predicted by LncADeep are also reasonable, as these pathways are
related with cancers. However, IPMiner-predicted proteins again give only two over-
represented KEGG pathways (PATH:ko05200 Pathways in cancer and PATH:ko04151 PI3K-
Akt signaling pathway), which are too general to specify the functions of TUNAR.
The above case studies showed that LncADeep can give informative functional anno-
tations which comply with the known functions of lncRNAs. For some lncRNAs whose




LncADeep predicts lncRNA-protein interactions, outperforming state-of-the-art tools and
showing several advantages. For instance, LncADeep uses mRMR for feature selection
and keeps only the most discriminative features, which helps to reduce overfitting. Be-
sides, LncADeep integrates both sequence and structure features, which is more robust
than using only one kind of feature. Furthermore, LncADeep is a user-friendly stand-alone
tool that can predict interactions in large scale. In contrast, RPISeq [106], RPI-pred [107]
and rpiCool [108] cannot be used for large scale interaction prediction, as RPISeq and RPI-
pred provide only online tools and rpiCool can predict only 250 lncRNA-protein pairs in
one run. Finally, as a lncRNA functional annotation tool, LncADeep offers annotations au-
tomatically for lncRNAs, and case studies have shown that LncADeep can provide helpful
functional annotations. Unlike the databases, such as lncRNA2Function [168] and FARNA
[169], relying on co-expression profiles, LncADeep gives functional annotations based on
only the sequence of lncRNAs and proteins, offering a new direction for annotating the
functions of lncRNAs. We expect that researchers can obtain experimental hints by inte-
grating the annotations from LncADeep and other databases (like lncRNA2Function and
FARNA).
To benchmark the time cost for predicting lncRNA- protein interactions, we paired one
alternative transcript of lncRNA HOTAIR (ENST00000439545) with 20,121 proteins and
tested tools on the same machine (Table S9) and measured the elapsed time. As RPISeq
[106], RPI-pred [107], and rpiCool [108] were not suitable for large-scale interaction pre-
diction, we benchmarked IPMiner [109], lncPro [86] and LncADeep. It took 4.5 minutes
for LncADeep to predict 20,121 lncRNA-protein pairs, while 30 minutes for IPMiner, and
247 minutes for lncPro. It is noteworthy that the time cost for LncADeep includes anno-
tating the functions for lncRNAs with over-represented KEGG and Reactome pathways.
Thus, for predicting lncRNA-protein interaction, LncADeep was the fastest among the
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tools that can predict interactions in large scale.
However, LncADeep can also suffer some drawbacks on predicting lncRNA-protein
interactions like other methods. First, the training dataset is relatively small, which covers
only a small amount of interacting lncRNA-protein pairs. To make full use of the capabil-
ity of deep learning, more training data is required to reveal the hidden interacting mech-
anisms between lncRNA and protein. Second, generating non-interacting lncRNA-protein
pairs by pairing lncRNAs and proteins and randomly choosing can be of risk, as some
lncRNA-protein pairs can be potential unverified interacting pairs, which might bias the
trained model. However, it is difficult to verify non-interacting lncRNA-proteins, because
to some extent, the interaction between lncRNA and protein can only be verified rather
than excluded. Therefore, training a model with only interacting pairs can be an alternative
strategy to address this problem, such as PRIPU [170], which trained a biased-SVM by
adapting its cost function. Finally, the function annotation of lncRNAs might also be bi-
ased since it is dependent on the predicted interacting proteins of lncRNAs. Nevertheless,
inferring the functions of lncRNAs through its interacting proteins provides an alternative
approach to investigate lncRNAs and can help to offer biological insights. In future work,
we plan to collect more experimentally verified interacting lncRNA-protein pairs and tackle
the problem related to non-interacting pairs. Since LncADeep is readily adapted, we ex-
pect to give more informative functional annotations for lncRNAs with additional training
datasets.
3.5 Conclusions
With deep learning, we presented a novel method for predicting lncRNA-protein inter-
actions and annotating lncRNA functions, which has also been implemented in our tool
LncADeep. In particular, to predict lncRNA-protein interactions, LncADeep first integrates
sequence and structure features of lncRNAs and proteins into deep neural networks. Based
on the comprehensive performance comparison between LncADeep and other tools, re-
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sults showed that LncADeep outperformed state-of-the-art tools, including lncPro, RPISeq,
RPI-pred, rpiCool, and IPMiner, for predicting lncRNA-protein interactions. Since accu-
rate lncRNA-protein interactions can help to infer the functions of lncRNAs, we then em-
ploy LncADeep to annotate the functions for the 27,384 lncRNAs collected in GENCODE
Release 24. With the interacting proteins of lncRNAs, LncADeep infers the functions
of these lncRNAs through KEGG and Reactome pathway enrichment analysis and func-
tional module detection. Consequently, LncADeep inferred 702,675 associations with 140
KEGG pathways and 1,839,272 associations with 422 Reactome pathways for the 27,384
lncRNAs, with an average of 25 KEGG and 67 Reactome pathways associated with each
lncRNA, conforming with the complexity of lncRNA functions. Besides, case studies on
well-studied lncRNAs showed that LncADeep’s functional annotations for lncRNAs ac-
cord with their known functions, indicating LncADeep can give helpful information for the
functions of lncRNAs. Last but not least, the performance of LncADeep demonstrated the
effectiveness of deep learning methods, which are capable of learning sophisticated hidden
structures in data. We expect that LncADeep can offer informative functional annotations
































































































Figure 3.5: An example of the detected functional module.
This is an example functional module detected for one alternative transcript of the lncRNA HO-




APPLICATION OF LNCADEEP AND CONCLUDING REMARKS OF THIS
DISSERTATION
As an illustration for the application of LncADeep, this chapter describes the steps to iden-
tify and functionally annotate lncRNAs from an RNA-seq dataset using LncADeep. Be-
sides, the conclusions from Appendices A and B are used for selecting a better RNA-seq
aligner. In the end, we give the concluding remarks of this dissertation.
4.1 Introduction
As a common category of non-invasive precursor lesion to breast, ductal carcinoma in situ
(DCIS) can evolve to invasive breast cancer, especially high-grade DCIS (HG-DCIS) [171,
172]. To investigate the molecular portrait of HG-DCIS, Abba, Martin C., et al. conducted
transcriptome analysis of pure high-grade DCIS (HG-DCIS) and normal breast epithelial
samples [172], and observed that lncRNA HOTAIR was upregulated in HG-DCIS. How-
ever, the transcriptome analysis in [172] focused on annotated transcripts and did not reveal
novel transcripts associated with HG-DCIS. To find if there are any novel transcripts po-
tentially related to HG-DCIS, especially novel lncRNAs, we downloaded their RNA-seq
dataset and conducted the lncRNA identification and annotation experiment. In particu-
lar, this experiment is intended to illustrate how to incorporate the tool (i.e., LncADeep)
proposed in this dissertation into RNA-seq data analysis.
4.2 Materials and methods
The workflow of the experiment is illustrated in Figure 4.1. To choose the better alignment
results for the subsequent analysis, we use two aligners, HISAT2 [17] and STAR [15]. We
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use StringTie [32] for sequence assembly and expression quantification, and Ballgown [43]
for differential expression analysis, as suggested in [26]. In the end, we use LncADeep for
lncRNA identification and annotation.
4.2.1 Dataset
Abba, Martin C. et. al. provided a molecular portrait of high-grade ductal carcinoma by
exome capture sequencing analysis, reduced representation bisulfite sequencing analysis
and RNA sequencing analysis [172]. Since we focus on RNA-seq data analysis, we use the
RNA-seq dataset as provided in [172] with accession number GSE69994. In particular, we
choose ten samples each for normal breast epithelium and HG-DCIS samples (Table 4.1),
which were sequenced by Illumina HiSeq2000 platform (76-nt paired-end reads and about
40 million tags per sample). The detailed description of the samples can be referred to in
[172].
4.2.2 RNA-seq data analysis
To select a better aligner for sequence alignment, we used two aligners, HISAT2 and STAR,
which belong to the fastest aligners. For reference genome and genome annotation, we
utilized UCSC hg 38 and GENCODE Release 26. After aligning the short reads to the ref-
erence genome, we computed two metrics, ReadsAlignedPercentage and ZeroMismatch-
Percentage, to profile the sequence alignment performance. According to the conclusions
of Appendices A and B, the aligner that produce higher ReadsAlignedPercentage and Ze-
roMismatchPercentage will be a better choice for gene expression estimation and differ-
ential expression analysis. Therefore, the alignment results generated by the better aligner
were used for the subsequent analysis.
Then, the alignment results were used for reference-guided sequence assembly and
transcript expression quantification using StringTie, where we used UCSC hg38 as refer-
ence genome and GENCODE Release 26 as genome annotation. To identify differentially
87
Table 4.1: Data description











11 SRR2040349 pure HG-DCIS
12 SRR2040350 pure HG-DCIS
13 SRR2040351 pure HG-DCIS
14 SRR2040352 pure HG-DCIS
15 SRR2040353 pure HG-DCIS
16 SRR2040354 pure HG-DCIS
17 SRR2040355 pure HG-DCIS
18 SRR2040356 pure HG-DCIS
19 SRR2040357 pure HG-DCIS
20 SRR2040358 pure HG-DCIS
expressed transcripts between normal breast epithelium and HG-DCIS samples, we used
Ballgown.
4.2.3 lncRNA identification and functional annotation
To identify and functionally annotate lncRNAs, we used the tool proposed in this disserta-
tion, LncADeep. In this study, we would like to find novel lncRNAs which are associated
with HG-DCIS. Therefore, first of all, we obtained differential expressed transcripts from
the results of Ballgown. Then, we filtered the differential expressed transcripts which have
been annotated in GENCODE Release 26, and kept unannotated transcripts for lncRNA
identification using LncADeep. Finally, we used LncADeep to predict interacting proteins
and infer functions for the novel lncRNAs.
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4.3 Results
For sequence alignment, HISAT2 consistently outperformed STAR with higher ReadsAligned-
Percentage (Figure 4.2) and ZeroMismatchPercentage (Figure 4.3). For HISAT2, the Read-
sAlignedPercentage of all samples were above 97%, while for STAR, the ReadsAligned-
Percentage of all samples ranged from 95% to 98%, which decreased the ReadsAligned-
Percentage by an additional ∼3%, indicating that most of the reads can be aligned. How-
ever, when comparing ZeroMismatchPercentage, HISAT2 showed higher advantage than
STAR, increasing the ZeroMismatchPercentage by an additional ∼8%. According to the
conclusions drawn from Appendices 2 and 3, we chose the alignment results generated by
HISAT2 for the subsequent analysis.
Using Ballgown (q-value less than 0.01), we found 2,680 differentially expressed tran-
scripts between normal and HG-DCIS samples, 66.8% (1,789) were annotated transcripts
and 33.2% (891) were novel transcripts. Among the annotated transcripts, 93.4% were
protein-coding transcripts and 6.6% were noncoding RNAs. To identify lncRNAs from
the novel transcripts, we used LncADeep and identified 412 novel lncRNAs. In HG-DCIS
samples, we found that 88% of annotated lncRNAs were over expressed (Figure 4.4), while
about 79% novel lncRNAs were over expressed (Figure 4.5). Among the annotated lncR-
NAs, we noticed that some had been identified as potentially associated with breast cancer,
such as RP11-111M22.4 [173], RP3-393E18.2 [173], and UCA1 [174]. Besides, we plot-
ted the expression level of six novel lncRNAs (Figure 4.6), which are the most significant
differentially expressed lncRNAs. The gtf annotation for these novel lncRNAs is list as
Figure 4.7. After identifying the novel lncRNAs, we then used LncADeep to predict their
interacting proteins and then infer their functions. As an example, we list the inferred
KEGG pathways for the novel lncRNA MSTRG.33791.3, where LncADeep successfully
predicted that MSTRG.33791.2 could be relevant to PATH:ko05224 Breast cancer (Figure
4.8).
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In this experiment, we incorporated the proposed tool (i.e., LncADeep) in this disser-
tation and conclusions drawn from Appendices A and B for RNA-seq data analysis. First,
according to the conclusions of Appendices A and B, for sequence alignment, the align-
ment results with higher ReadsAlignedPercentage and ZeroMismatchPercentage were used
for the subsequent analysis, which tend to yield more accurate analysis results. Second, as
a state-of-the-art tool for lncRNA identification and functional annotation, LncADeep was
used to identify novel lncRNAs and annotate their functions. In particular, we found 412
novel lncRNAs which can be potentially associated with HG-DCIS, and the function an-
notations for these lncRNAs also correlated them to breast cancer, to which HG-DCIS can
evolve. Although further verification for these lncRNAs and their function annotations are
needed, this experiment demonstrated that LncADeep could help to identify and function-
ally annotate novel lncRNAs and provide helpful hints for biologists.
4.4 Concluding remarks of this dissertation
This dissertation proposed LncADeep (Figure 4.9), an ab initio lncRNA identification and
annotation tool based on deep learning methods.
LncADeep is composed of two parts, the first part is to identify lncRNA (Figure 4.9A)
based on a deep learning algorithm, deep belief networks. For lncRNA identification, we
integrated both intrinsic and homology features for model construction. In particular, we
constructed two models, one targeting full-length transcripts, and the other targeting tran-
scripts including full- and partial-length. The model targeting full-length transcripts will be
helpful when the third generation sequencing technologies, which suffice for long read se-
quencing, becomes prevalent. Meanwhile, in current RNA-seq dataset, the assembled tran-
scripts from the short reads are composed of full- and partial-length, while most lncRNA
identification tools focus on identifying lncRNA from full-length transcripts. Therefore,
we designed a model targeting transcripts including full- and partial-length. Specifically,
we proposed LCDS-based model to address the problem about locating CDS from partial-
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length mRNAs, and majority voting to improve the generalization ability. Results showed
that LncADeep outperformed state-of-the-art lncRNA identification tools, including CPC,
CPC2, CPAT, CNCI, COME, lncRScan-SVM, longdist, lncRNA-MFDL, lncScore, FEElnc
and PLEK, on full-length transcripts (accuracy of 97.7%), as well as transcripts includ-
ing full- and partial-length (accuracy of 94.2%). Besides, as a reference-free (or ab initio)
tool, LncADeep still outperform other tools on cross-species lncRNA identification on full-
length transcripts (accuracy of 96.7%) and transcripts of full- and partial-length (94.2%).
The second part is to predict lncRNA-protein interactions and infer lncRNA functions
(Figure 4.9B). To functionally annotate lncRNAs, we developed a method for predicting
lncRNA-protein interactions, and then used the predicted interacting proteins for infer-
ring the functions of lncRNAs. Through integrating both sequence and structure infor-
mation into a deep neural network for predicting lncRNA-protein interaction, LncADeep
outperformed stat-of-the-art tools (including RPISeq, RPI-pred, rpiCool, lncPro, and IP-
Miner) with an accuracy of 90.8%. With the predicted interacting proteins of lncRNAs, we
then employed LncADeep to annotate the functions for the 27,384 lncRNAs collected in
GENCODE Release 24, through KEGG and Reactome pathway enrichment analysis, and
functional module detection. Consequently, LncADeep inferred an average of 25 KEGG
and 67 Reactome pathways associated with each lncRNA, according with the complex-
ity of lncRNA functions. In addition, examples on well-studied lncRNAs showed that
LncADeep’s functional annotations for lncRNAs comply with their known functions.
To illustrate the steps to identify and functionally annotate lncRNAs from a RNA-seq
dataset using LncADeep, we conducted a lncRNA identification and functional annotation
experiment using a public RNA-seq dataset of high-grade ductal carcinoma in situ (HG-
DCIS), which can evolve to invasive breast cancer. In particular, using LncADeep, we
identified 412 differentially expressed novel lncRNAs which can be involved with HG-
DCIS, and the function annotations for these lncRNAs also associated them with pathways
related to breast cancer, to which HG-DCIS can evolve.
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In summary, we proposed LncADeep (http://cqb.pku.edu.cn/ZhuLab/LncADeep), which
is, to our best knowledge, the first tool that can identify lncRNAs and automatically provide
functional annotations for lncRNAs. We expect that not only can LncADeep contribute to
identifying lncRNAs, but also provide helpful functional information for investigating the
associations among lncRNAs, gene regulation and diseases, and then facilitate the large-
scale automatic genome annotation.
In future work, we plan to collect more experimentally verified interacting lncRNA-
protein pairs and further improve the performance of predicting lncRNA-protein interac-
tion, which will in turn improve the inference of lncRNA functions. Since LncADeep is
readily adapted, we expect to give more informative functional annotations for lncRNAs
with additional training datasets. Besides, we plan to implement a webserver integrating

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































KEGG_path_ID KEGG_pathway p_value adj_p_value
PATH:ko04512 ECM-receptor interaction 1.90E-10 5.20E-09
PATH:ko05224 Breast cancer 3.20E-05 4.30E-04
PATH:ko05217 Basal cell carcinoma 1.00E-04 8.80E-04
PATH:ko04510 Focal adhesion 1.30E-04 8.80E-04
PATH:ko04916 Melanogenesis 3.80E-04 1.90E-03
PATH:ko04310 Wnt signaling pathway 4.90E-04 1.90E-03
PATH:ko04390 Hippo signaling pathway 4.90E-04 1.90E-03
PATH:ko04151 PI3K-Akt signaling pathway 3.00E-03 1.00E-02
PATH:ko04150 mTOR signaling pathway 4.40E-03 1.30E-02
PATH:ko00360 Phenylalanine metabolism 1.10E-02 2.90E-02
PATH:ko00680 Methane metabolism 1.30E-02 3.30E-02
PATH:ko05200 Pathways in cancer 1.60E-02 3.40E-02
PATH:ko05205 Proteoglycans in cancer 1.50E-02 3.40E-02
PATH:ko04016 MAPK signaling pathway - plant 1.80E-02 3.40E-02
PATH:ko05133 Pertussis 2.60E-02 4.40E-02
PATH:ko04330 Notch signaling pathway 2.90E-02 4.40E-02
PATH:ko04974 Protein digestion and absorption 2.90E-02 4.40E-02
PATH:ko04550 Signaling pathways regulating pluripotency of stem cells 2.60E-02 4.40E-02
PATH:ko05144 Malaria 3.20E-02 4.50E-02
PATH:ko04610 Complement and coagulation cascades 4.00E-02 4.50E-02
PATH:ko05150 Staphylococcus aureus infection 4.00E-02 4.50E-02
PATH:ko01210 2-Oxocarboxylic acid metabolism 3.70E-02 4.50E-02
PATH:ko04933 AGE-RAGE signaling pathway in diabetic complications 3.80E-02 4.50E-02
PATH:ko04145 Phagosome 3.40E-02 4.50E-02
PATH:ko04971 Gastric acid secretion 4.60E-02 4.70E-02
PATH:ko04340 Hedgehog signaling pathway 4.70E-02 4.70E-02
PATH:ko00532 Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 4.60E-02 4.70E-02
















































Figure 4.9: The flowchart of LncADeep.
(A) We construct two models for lncRNA identification, one for full-length transcripts, and the
other for transcripts including full- and partial-length. F1 to F6 refer to ORF length and coverage,
the EDP of ORF, Mean hexamer score, Fickett nucleotide features, HMMER index, and UTR
length and GC content, respectively. f1 to f3 represent LCDS length and coverage, the EDP of
LCDS, and Mean hexamer score, respectively. (B) We use sequence and structure features for
the prediction of lncRNA-protein interaction. X1, X
′
1 and X2 refer to sequence features, sequence
features after feature selection, and structure features, respectively. The identified lncRNAs can
be input for predicting lncRNA-protein interactions, then the interacting proteins can be used for





THE IMPACT OF RNA-SEQ ALIGNERS ON DEG DETECTION
Components of this chapter have been published as: Yang, C., Wu, P. Y., Phan, J. H.,
& Wang, M. D. (2014, December). The impact of RNA-seq alignment pipeline on de-
tection of differentially expressed genes. In Signal and Information Processing (Global-
SIP), 2014 IEEE Global Conference on (pp. 1376-1379). IEEE. DOI: 10.1109/Global-
SIP.2014.7032351
A.1 Abstract
RNA-seq data analysis pipelines are generally composed of sequence alignment, expres-
sion quantification, expression normalization, and differentially expressed gene (DEG) de-
tection. Each step has numerous specific tools or algorithms, so we cannot explore all
combinatorial pipelines and provide a comprehensive comparison of pipeline performance.
To understand the mechanism of RNA-seq data analysis pipelines and provide some use-
ful information for pipeline selection, we believe it is necessary to analyze the interactions
among pipeline components. In this paper, by combining different alignment algorithms
with the same quantification, normalization, and DEG detection tools, we construct nine
RNA-seq pipelines to analyze the impact of RNA-seq alignment on downstream appli-
cations of gene expression estimates. Specifically, we find moderate linear correlation




Facilitated by next-generation sequencing (NGS) technology, high-throughput RNA se-
quencing (RNA-seq) interrogates the comprehensive profile of transcriptomes [4], enabling
detailed identification of gene isoforms, translocation events, nucleotide variations, and
post-transcriptional base modifications [175, 3].
A standard RNA-seq data analysis pipeline consists of (1) sequence read mapping, (2)
expression quantification, (3) expression normalization, and (4) differentially expressed
gene (DEG) detection, and each step has a considerable number of bioinformatics tools.
Since a pipeline consists of a sequence of the selected tools from each step, the combina-
tion of these tools provides a number of choices, yet raises the following question: Which
pipeline should we use? Intuitively, the best pipeline would be composed of the best tool
in each step. Researchers have conducted comparative analyses for the sequence alignment
[176], expression quantification [177], expression normalization, and DEG detection [175]
tools. The evaluation of the tools in a pipeline may be informative for pipeline selection.
Based on this evaluation, we might select the most accurate alignment, quantification, nor-
malization, and DEG detection tools to construct a pipeline. However, the combination of
the best tools does not ensure an accurate analysis result, especially when the performance
of the tool is sample-related. For instance, Grant et al. [176] found that the base-level ac-
curacy of alignment pipelines varies among samples. Until now, few studies systematically
compared the performance of RNA-seq pipelines. Therefore, it remains uncertain whether
the combination of best tools will produce a better-performing pipeline. To provide helpful
information for pipeline selection and understand the mechanism of RNA-seq data analy-
sis pipelines, we believe it is necessary to investigate the associations among the steps in
RNA-seq pipelines. Once we know how the alignment step affects the final results (e.g.,
DEG detection), we can determine which alignment tool we should use and even estimate
the number of DEGs with alignment metrics that can profile the alignment results.
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In this paper, we analyze the impact of RNA-seq alignment pipeline on downstream
applications of gene expression estimates, e.g., DEG detection. The rest of this paper is
organized as follows. Section II introduces the experimental design and data analysis.
Section III discusses the results and the potential impact of alignment on gene expression
estimates. Finally, Section IV concludes our work.
A.3 Methodology
The workflow of this study is shown in Figure A.1. To analyze the impact of alignment on
gene expression estimates, we vary the alignment tools (Bowtie2 [20], BWA [178], GSNAP
[179], Novoalign [180], and WHAM [22]) while using a fixed quantification tool (RSEM
[31]), a normalization algorithm (trimmed mean of M-values normalization, TMM [45]),
and a DEG detection tool (edgeR [42]).
A.3.1 Dataset
The dataset consists of SEQC samples A and B [181], which contain Stratagenes Universal
Human Reference RNA and Ambions Human Brain Reference RNA, respectively. The
samples were sequenced with the Illumina HiSeq 2000 platform at three official sequencing
sites, including the Beijing Genomics Institute (BGI), the Weill Cornell Medical College
(CNL) and the Mayo Clinic (MAY). In this paper, we use only the data sequenced at BGI,
which includes four replicates with around five million paired-end reads for each replicate.
Each replicate has sixteen lanes, and we use the first two lanes.
A.3.2 Sequence Mapping and Expression Quantification
To analyze the impact of alignment on gene expression estimates, we vary the alignment
tools, including Bowtie2, BWA, GSNAP, Novoalign and WHAM. For Bowtie2, GSNAP,
Novoalign, and WHAM, we use two sequence alignment reporting strategies, single-hit
and multiple-hit. Whereas single-hit aligners report only one location for a single read,
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Figure A.1: The workflow for investigating the association between RNA-seq alignment
profiles and gene expression estimates.
multiple-hit aligners can report more than one location. BWA only reports single-hit align-
ments. We use the same reference genome (i.e., UCSC hg19) and the same genome anno-
tation (i.e., AceView [182]) for all alignment pipelines. For gene expression quantification,
we use RSEM with both the AceView transcriptome [182] and hg19 as reference genomes.
The data generated from RSEM are in the form of gene counts.
A.3.3 Alignment Profiles
We characterize alignment profiles by using the percentage of reads aligned with zero and
one mismatch as alignment metrics. Reads aligned with zero or one mismatch are more
likely to account for gene expression estimates. We extract the percentage of reads aligned
with no mismatch denoted as ZeroMismatchPercentage, and those with at most one mis-
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match denoted by OneMismatchPercentage. In addition, we count the number of reads
aligned with single- or multiple-hit reporting. Since each sample has four replicates, we
first compute the alignment metrics for each replicate, and then calculate the average as the
alignment metrics of the sample.
A.3.4 DEG Detection Specificity
For gene expression estimates, evaluating every gene is not possible, especially when most
genes have similar expression. As a result, we propose to use DEG detection as a down-
stream evaluation of gene expression estimates. We identify DEGs using the edgeR pack-
age in R. Before detecting DEGs, we use TMM (trimmed mean of M-values normalization)
to normalize the data. Since each sample has four replicates (Replicates 1, 2, 3, and 4), we
compare two replicates with the other two to detect DEGs (i.e., Replicates 1 and 2 vs.
Replicates 3 and 4, Replicates 1 and 3 vs. Replicates 2 and 4, and Replicates 1 and 4 vs.
Replicates 2 and 3). With various combinations, we have three groups, that is, we can get
three DEG numbers for each sample. Because replicates come from the same sample, ide-
ally the number of DEGs should be close to zero based on the assumption that the pipeline
performs well. To capture and model this assumption, we define “DEG index” as “each
pipeline’s total DEG number” to represent the pipeline’s quality. That is, for each pipeline,
we add the three DEG numbers as its DEG index. The DEG index can quantify differences
among pipelines. Meanwhile, the only variable in the comparison of pipelines is the align-
ment tool, which will be the only source of the discrepancy among the DEG indices of the
pipelines. To investigate the effects of different DEG adjusted p-value thresholds on our
observation, we detected DEGs with different thresholds (from p = 0.01 to 0.1). As larger
adjusted p-value thresholds indicate looser constraints for DEGs, we expected more DEGs
when we gradually increased the thresholds.
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A.4 Results and discussion
Figures A.2 and A.3 show that, for most alignment tools for both Samples A and B, more
than 60% of reads aligned with zero mismatch, and over 80% of reads aligned with zero
or one mismatch, suggesting that the percentage of zero and one mismatch can cover the
majority of reads in the alignment files. For both Samples A and B, alignment pipelines
showed almost the same trend in ZeroMismatchPercentage and OneMismatchPercentage,
suggesting that ZeroMismatchPercentage and OneMismatchPercentage in the alignment
tools might be independent of the samples. We also verified that single-hit alignment
pipelines only report one hit for each read; in contrast, multi-hit alignment pipelines can
report several hits for some reads (Figures A.4 and A.5).
Figure A.2: The alignment profiles of Sample A (percentage of reads aligned with zero or
one mismatch).
Figures A.6 and A.7 show the key finding of our study: The DEG indices of RNA-seq
pipelines have moderate linear correlation with the percentage of reads aligned with zero
or one mismatch (ZeroMismatchPercentage and OneMismatchPercentage). Figures A.6
and A.7 show the impact of alignment pipelines on the DEG indices of Samples A and
B, respectively. Note that single- and multiple-hit alignment strategies are distinctive. We
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Figure A.3: The alignment profiles of Sample B (percentage of reads aligned with zero or
one mismatch).
Figure A.4: The alignment profiles Sample A (percentage of reads aligned with single-hit
or multiple-hit).
use linear regression to measure their impact on DEG indices separately. For Sample A,
both multiple-hit (blue boxes in Figure A.6) and single-hit (red boxes in Figure A.6) DEG
indices of alignment pipelines tended to decrease as ZeroMismatchPercentage increased.
However, for the OneMismatchPercentage, the correlations between the DEG indices and
the alignment pipelines were insignificant (Table A.1). As for Sample B (Figure A.7 and
Table A.2), both multiand single-hit DEG indices of the alignment pipeline also had lin-
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Figure A.5: The alignment profiles of sample B (percentage of reads aligned with single-hit
or multiple-hit).
ear correlation with ZeroMismatchPercentage. Unlike that of Sample A, both multi- and
single-hit DEG indices of the alignment pipeline exhibited a moderate linear correlation
with OneMismatchPercentage in Sample B. This discrepancy might relate to the sample
differences. Some sample-related metrics can also account for the impact of alignment
pipelines on DEG index apart from the two metrics above. For Sample A, the sample-
related metrics might fluctuate among results of alignment pipelines, while for Sample B,
the other metrics may be consistent, which leads to that discrepancy. In addition, compared
with single-hit alignment algorithms, ZeroMismatchPercentage of multiple-hit alignment
algorithms have stronger linear impact on DEG index (Table A.1 and A.2). Overall, our
study discovered an alignment pipeline metric ZeroMismatchPercentage with moderate
linear impact on gene expression estimation.
A.5 Conclusion
We investigated the impact of alignment pipelines on gene expression estimates of RNA-
seq pipelines. First, we constructed nine different RNA-seq pipelines by combining dif-
ferent alignment pipelines with the same quantification, normalization, and DEG detection
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multiple-hit single-hit multiple-hit single-hit
0.01 -0.7901 -0.0478 -0.8774 -0.0387
0.02 -0.7518 -0.2361 -0.8842 -0.2792
0.03 -0.8721 -0.2456 -0.9610** -0.2864
0.04 -0.8537 -0.2841 -0.9363* -0.3927
0.05 -0.7537 -0.3958 -0.8616 -0.4101
0.06 -0.6826 -0.5797 -0.8091 -0.7022
0.07 -0.7611 -0.5829 -0.8792 -0.7764
0.08 -0.75 -0.3759 -0.8775 -0.6194
0.09 -0.7622 -0.3549 -0.8867 -0.5777
0.1 -0.7023 -0.3952 -0.844 -0.6163
Significance codes: ‘**’ p-value < 0.05, ‘*’ p-value < 0.1.




multiple-hit single-hit multiple-hit single-hit
0.01 -0.5828 -0.3632 -0.7507 -0.7059
0.02 -0.7194 -0.553 -0.8585 -0.8246*
0.03 -0.7689 -0.698 -0.894 -0.8754*
0.04 -0.8104 -0.6447 -0.9208* -0.8109*
0.05 -0.8026 -0.7132 -0.9142* -0.8697*
0.06 -0.8234 -0.7764 -0.9175* -0.9187**
0.07 -0.8689 -0.7473 -0.9452* -0.9363**
0.08 -0.8546 -0.7435 -0.9315* -0.9475**
0.09 -0.8499 -0.6872 -0.9345* -0.9246**
0.1 -0.8091 -0.6547 -0.9118* -0.9034**
Significance codes: ‘**’ p-value < 0.05, ‘*’ p-value < 0.1.
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Figure A.6: The impact of alignment pipelines on gene expression estimation (Sample A).
tools. With these RNA-seq pipelines, we computed DEG indices for real datasets. Then,
to profile alignment pipelines, we calculated the percentages of reads aligned with zero
and one mismatch. Our study indicated that the ZeroMismatchPercentage of alignment
pipelines had moderate linear impact on DEG index. Thus, we recommend constructing
RNA-seq pipelines for DEG detection by choosing alignment tools that result in high Ze-
roMismatchPercentage. Although this preliminary study focused on two samples, nine
different pipelines, and two metrics, we plan to include additional samples (i.e., SEQC
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Figure A.7: The impact of alignment pipelines on gene expression estimation (Sample B).
samples C and D), pipelines, and metrics in a more comprehensive study.
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APPENDIX B
THE IMPACT OF RNA-SEQ ALIGNERS ON GENE EXPRESSION ESTIMATION
Components of this chapter have been published as: Yang, C., Wu, P. Y., Tong, L., Phan,
J., & Wang, M. (2015, September). The impact of RNA-seq aligners on gene expression
estimation. In Proceedings of the 6th ACM Conference on Bioinformatics, Computational
Biology and Health Informatics (pp. 462-471). ACM. doi:10.1145/2808719.2808767
B.1 Abstract
While numerous RNA-seq data analysis pipelines are available, research has shown that the
choice of pipeline influences the results of differentially expressed gene detection and gene
expression estimation. Gene expression estimation is a key step in RNA-seq data anal-
ysis, since the accuracy of gene expression estimates profoundly affects the subsequent
analysis. Generally, gene expression estimation involves sequence alignment and quantifi-
cation, and accurate gene expression estimation requires accurate alignment. However, the
impact of aligners on gene expression estimation remains unclear. We address this need
by constructing nine pipelines consisting of nine spliced aligners and one quantifier. We
then use simulated data to investigate the impact of aligners on gene expression estima-
tion. To evaluate alignment, we introduce three alignment performance metrics, (1) the
percentage of reads aligned, (2) the percentage of reads aligned with zero mismatch (Ze-
roMismatchPercentage), and (3) the percentage of reads aligned with at most one mismatch
(ZeroOneMismatchPercentage). We then evaluate the impact of alignment performance on
gene expression estimation using three metrics, (1) gene detection accuracy, (2) the num-
ber of genes falsely quantified (FalseExpNum), and (3) the number of genes with falsely
estimated fold changes (FalseFcNum). We found that among various pipelines, FalseExp-
Num and FalseFcNum are correlated. Moreover, FalseExpNum is linearly correlated with
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the percentage of reads aligned and ZeroMismatchPercentage, and FalseFcNum is linearly
correlated with ZeroMismatchPercentage. Because of this correlation, the percentage of
reads aligned and ZeroMismatchPercentage may be used to assess the performance of gene
expression estimation for all RNA-seq datasets.
B.2 Introduction
RNA sequencing (i.e., RNA-seq) refers to the technologies and applications for high-
throughput sequencing of RNA [3]. With the development of next-generation sequencing
technology, RNA-seq has evolved to be a promising technology that plays an important role
in several applications such as differential expression analysis, single nucleotide variation
discovery, fusion gene detection, and co-expression network construction [25, 183, 184,
185, 186].
Typically, an RNA-seq data analysis pipeline includes (1) sequence read alignment, (2)
expression quantification, (3) expression normalization, and (4) differentially expressed
gene (DEG) detection. For each step of the pipeline, many algorithms or tools have been
developed. Being aware of a large amount of combinations of RNA-seq data analysis
pipelines, researchers have conducted comparative and quality control studies [181, 187,
44, 188, 189, 190, 176, 191] for quantifying the performance of tools or algorithms and
ensuring the accuracy and reproducibility of RNA-seq. Conclusions from most studies
support that the choice of pipelines affects the analysis results. For example, Grant et
al. [176] evaluated various alignment algorithms and observed the discrepancy of align-
ment performance. Fonseca et al. [187] combined various alignment algorithms and three
quantification tools to analyze the variance of detected and true gene expression levels,
and proved that different analysis pipelines affected the gene expression levels. Soneson
et al. [44] compared methods for differential expression analysis and found that shared
differentially expressed genes detected by different methods varied significantly. Most
of these studies focus on the comparison of algorithms or tools belonging to each step,
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which cannot illustrate how the impact propagates through the steps of RNA-seq analysis
pipelines. Although Fonseca et al. [187] combined aligners and quantifiers to investigate
the variance of detected and true gene expression, they mainly compared the performance
of the pipelines, and did not explain how alignment pipelines affected the gene expres-
sion estimates. The SEQC/MAQC-III consortium conducted a large-scale, multisite, cross-
platform RNA-seq study that aimed to build standards for RNA-seq research from sample
preparation to downstream analytics. They found that RNA-seq measurement performance
depended on platforms and data analysis pipelines [181]. However, the choice of which
pipeline researchers should apply still remains unclear. To solve this problem, the intuition
is to conduct a pipeline-level comparative study for RNA-seq data analysis. However, the
huge amount of pipelines impedes a comprehensive evaluation. Even though a comprehen-
sive comparative study could be realized for some datasets, we cannot be assured of finding
a pipeline that always outperforms other pipelines for all datasets. To ensure the accuracy
and reproducibility of RNA-seq data analysis results, we need to investigate the cause of
the performance variance among RNAseq data analysis pipelines. Indeed, if we can iden-
tify the impact of error propagation of the RNA-seq data analysis pipelines, we might be
able to design the pipeline or redesign the tool or algorithms of each step to achieve better
performance.
Gene expression quantification is a key step in the RNA-seq data analysis pipeline,
and the accuracy of expression quantification can profoundly affect the subsequent anal-
ysis. However, accurate gene expression quantification requires accurate sequence read
alignment. As previously mentioned, Fonseca et al. [187] evaluated the effect of differ-
ent analysis pipelines on gene expression estimation and assessed the difference between
true and estimated expression, but they mainly focused on the comparison of the pipelines
and did not reveal why and how the choice of aligners and quantifiers influences the gene
expression level. We investigate the impact of aligners on gene expression estimation and




The workflow of our study is shown in Figure B.1. To investigate the impact of RNA-seq
aligners on gene expression estimation, we vary aligners which are specifically designed
for genome alignment. For quantification tool, we use a fixed tool: HTSeq [30].
Figure B.1: The workflow of experimental design and data analysis.
B.3.1 Simulation of RNA-seq Dataset
Real RNA-seq datasets do not contain ground-truth information. To facilitate the investi-
gation of the impact of RNA-seq aligners on gene expression estimation, we need to know
the true expression level of every gene. Therefore, we use a simulated RNA-seq dataset for
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this study. We employ rlsim [192] with simNGS [193] to generate RNA-seq data. rlsim
integrates a collection of tools to simulate RNA-seq library construction [192] and can gen-
erate the simulated RNA fragments. simNGS can simulate observed reads from Illumina
sequencing machines and incorporate noise due to sequencing. We apply rlsim to generate
RNA fragments and simNGS to simulate RNA-seq reads.
For constructing the RNA library, we use the default setting of rlsim to generate 20
million RNA fragments based on the RefSeq gene annotation and the UCSC hg19 refer-
ence genome. First, we employ the “sel” tool from rlsim package to sample the expression
level of each transcript from a mixture of gamma distributions including Gamma(5000,
0.1) and Gamma(10000, 100). Second, we adopt rlsim to generate RNA fragments from
the previous FASTA file. With RNA fragments, we then employ simNGS to simulate
paired-end reads: we use “s 6 4x.runfile”, which is shipped with the simNGS package, to
simulate 101bp paired-end reads from each fragment. Besides the absolute expression of
each gene, we are also interested in the relative gene expression levels. Thus, we simulate
two samples-Samples A and B-each of which has five replicates, and each replicate has 20
million paired-end reads. For gene expression fold changes, we follow the simulation strat-
egy proposed by Zheng et al. [194]. Using the same simulated expression levels generated
by “sel”, we artificially introduce some differentially expressed genes with predefined fold
changes. Sample A was simulated by using the original expression profile. For Sample B,
we randomly choose 10% genes to be overexpressed, 10% genes underexpressed, and the
rest 80% genes remain unchanged. Among all overexpressed and underexpressed genes,
we randomly and equally assign a predefined fold change to each gene. Table B.1 summa-
rizes the preset gene expression fold change. With these settings, we obtain two samples
with built-in truths about absolute gene expression and relative expression fold changes.
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a Total number of genes.
B.3.2 Sequence Alignment
To analyze the impact of alignment on gene expression estimation, we use various align-
ment tools and a fixed quantification tool to control variables. Until now, researchers have
developed many RNA-seq alignment tools or pipelines, which can be categorized as tran-
scriptome aligners and genome aligners. Transcriptome aligners can reduce the alignment
complexity by aligning sequence reads to known transcripts, while genome aligners di-
rectly align the reads to the genome and must address the reads derived from splice junc-
tions [195]. However, transcriptome aligners are usually combined with isoform expression
quantification, which need to be translated to gene expression levels if we are interested in
the latter. Therefore, we select nine recently released spliced aligners, including Tophat2
[14], STAR [15], MapSplice [16], GSNAP spliced [179], PASSION [19], OLego [196],
Subread [197], SOAPSplice [198], and GEM [18]. We use UCSC hg19 as the reference
genome. If the alignment tool supports multiple-hit mapping strategy, such as Tophat2,
GSNAP spliced, OLEGO, STAR, and Subread, we allow up to twenty hits for each read.
For other options, we follow default settings.
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B.3.3 Expression Quantification
For gene expression quantification, we use HTSeq (the intersection-nonempty mode) with
RefSeq as the genome annotation. HTSeq is a count-based quantification tool, enabling us
to compare the estimated gene expression to the built-in truth. Because counting multiple-
hit reads (reads that have multiple mapping locations) might cause false positive differ-
entially expressed genes [30], the default setting of HTSeq tends to discard all of these
multiple-hit reads. However, discarding the multiple-hit reads may also incur false neg-
ative errors in terms of gene detection. For example, if one and only one mapping of a
multiple-hit read is correct and we discard it, then the expression of the associated gene
will be underestimated. In this study, we choose to keep all multiple-hit reads by removing
the tag that HTSeq uses to identify the multiple-hit reads.
B.3.4 Performance Evaluation
Alignment Profile Construction
Here we propose to use the percentage of reads aligned (ReadsAlignedPercentage), the per-
centage of reads aligned with zero mismatch (ZeroMismatchPercentage) and at most one
mismatch (ZeroOneMismatchPercentage) as the metrics for assessing alignment quality.
We hypothesize that the percentage of reads aligned can quantify the mapping capability
of an alignment pipeline, and reads aligned with less than one mismatch are more reliable
for downstream expression estimates.
Gene Expression Evaluation
After quantifying the gene expression, we get the gene count number for each gene. Since
we already know the true expression for each gene, we can compare the estimated gene
expression to the built-in truth. However, not all reads can be aligned through alignment,
and not all reads will be assigned to a specific gene (e.g., assigned to no-feature and am-
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Table B.2: Definition of gene detection accuracy
True expression









biguous) during quantification, which indicates a portion of reads will be discarded and
cannot account for the gene expression. If we directly compare estimated expression to
true expression, discrepancy between them is definitely expected. To compensate for this
discrepancy, we propose to use the following two metrics to measure expression accuracy:
(i) the detection ability of genes (Table B.2) measured by Accuracy = (TP + TN) / (TP + TN
+ FP + FN) and (ii) the number of genes falsely quantified (Notation: FalseExpNum) mea-
sured by (Equation B.1), which normalizes the difference between gene counts by median







where Ti and Ri represent the true and estimated expression level of the i-th gene after
normalization, respectively; I is the indicator function (I = 1 if the formula in parentheses
is true; I = 0 otherwise; we consider 0/0 = 0); Threshold is between 0.2 and 1; and n is the
total number of genes. To determine a falsely quantified gene, we incoporate the threshold,
which quantifies the deviations compared with true expression level. Generally, a larger
threshold indicates more tolerance to the deviations.
Fold-change Variance Evaluation
Besides the absolute expression accuracy, we also evaluate the relative expression accuracy
(fold changes). We compute gene expression fold changes between Samples A and B using
estimated gene expression. We then compare the estimated fold changes to the ground truth.
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We count the number of genes with falsely estimated fold changes (Notation: FalseFcNum)







where TFCi and EFCi means the true and estimated fold change of the i-th gene,
respectively; I is the indicator function (I = 1 if the formula in parentheses is true; I = 0
otherwise; we consider 0/0 = 0); Threshold is between 0.2 and 1; and n is the total number
of genes. Also, threshold is used to quantify the deviations of true fold change.
Correlation
Once we acquire the alignment profile (i.e., ReadsAlignedPercentage, ZeroMismatchPer-
centage, and ZeroOneMismatchPercentage) and the aforementioned evaluation metrics
(i.e., the gene detection accuracy, FalseExpNum, and FalseFcNum) we apply linear re-
gression analysis to model their relationship. Since the only difference among the gene
expression estimation pipelines we use is the aligner, if any discrepancy exists in the gene
expression, the only source would be aligner. Thus, the logic would be treating alignment
profile as the explanatory variable, and the evaluation of gene expression as dependent vari-
able. For real data, we do not know the built-in truth, and we can only compute the metrics
for alignment profiles. If we can observe some correlation between alignment profile and
expression evaluation, we might be able to predict the expression performance based on
the alignment profile. Therefore, we fit linear regression between alignment profile and
the evaluation metrics under various threshold values (to verify if the alignment profiles
correlate with expression evaluation), and we compute adjusted R2 value for each one.
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B.4 Results and discussion
B.4.1 Alignment Profile
At the first sight, we might total the ratio of correctly aligned reads as the metric of align-
ment pipelines performance, since we know the true mapping location of each read. How-
ever, for real data, we are not aware of the true alignment of every read, which negates the
feasibility to employ the alignment accuracy as the metric. Thus, we introduce alternative
metrics. The first metric in the alignment profile is the percentage of reads aligned. For
every aligner, we observed that the percentage of reads aligned (ReadsAlignedPercentage)
were almost of the same value in both Samples A and B, therefore we plotted them in
one figure (Figure B.2). The small error bars indicate consistent performance among both
Samples A and B. Except GEM, the ReadsAlignedPercentage of most aligners were over
90%.
Figure B.2: The percentage of reads aligned.
Then, with the alignment results, we computed the percentage of reads aligned with
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GEM 9 9 9
GSNAP_spliced 3 2 2
MapSplice 1 6 7
Olego 8 5 6
PASSION 4 1 5
SOAPsplice 6 7 8
STAR 2 4 3
Subread 5 8 4
Tophat2 7 3 1
zero or one mismatch. For each aligner, we found that both ZeroMismatchPercentage and
ZeroOneMismatchPercentage were almost the same in Samples A and B. As we can see
from Figure B.3 (each column includes all the replicates of Samples A and B), the reads
aligned with zero and one mismatch can account for the majority of the aligned reads
(over 80%). In addition, we used ANOVA to analyze the difference among the metrics
of all the aligners (we apply ANOVA to any two aligners metrics). And we observed that
ReadsAlignedPercentage, ZeroMismatchPercentage and ZeroOneMismatchPercentage are
all significantly different among different aligners since all the p-values are less than 0.001.
We also ranked the aligners according to the above three metrics separately (Table B.3).
B.4.2 Expression and Fold-change Evaluation
Figure B.4 displays the gene detection accuracy of each pipeline. For most pipelines, gene
detection accuracy is at the same level (up to 90%), and show little difference, indicating
that the gene detection accuracy might not be an appropriate metric for the evaluation of
gene expression.
For the number of genes falsely quantified (FalseExpNum), we observed significant
discrepancy among pipelines (Figure B.5). With the threshold increases, FalseExpNum
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Figure B.3: The percentage of reads aligned with 0 or 1 mismatch.
Figure B.4: The accuracy of gene detection.
decreases. This is reasonable because a larger threshold means higher tolerance to false
quantified genes, which results in less number of genes falsely quantified. From Figure B.6,
we can observe that the number of genes with falsely estimated fold changes (FalseFcNum)
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also varies among pipelines and shows a similar trend with increase of threshold.
Figure B.5: The number of genes falsely quantified.
Logically, only the genes falsely quantified might have false estimated fold change.
To investigate the consistency between the two metrics (FalseExpNum and FalseFcNum),
we computed the Pearson correlation coefficient (Table B.4). As we can see in Table B.4,
FalseExpNum and FalseFcNum show significant linear correlation with each other, sug-
gesting that both FalseExpNum and FalseFcNum can be equally employed as the metric
of gene expression estimates. However, comparing FalseExpNum and FalseFcNum, we
observed that FalseExpNum was generally larger than FalseFcNum, indicating that even
though some genes have been falsely quantified, the fold changes of these genes will not
be affected.
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Figure B.6: The number of genes with falsely estimated fold-change.
B.4.3 Correlation
Obtaining the alignment profile (ReadsAlignedPercentage, ZeroMismatchPercentage and
ZeroOneMismatchPercentage) and the expression evaluation (FalseExpNum and FalseFc-
Num), we applied linear regression to fit their relationship. Since three metrics of align-
ment profile were available, we fitted the model (1) with only ReadsAlignedPercentage,
(2) with ZeroMismatchPercentage, (3) with ZeroOneMismatchPercentage, (4) with both
ReadsAlignedPercentage and ZeroMismatchPercentage, and (5) with both ReadsAligned-
Percentage and ZeroOneMismatchPercentage. From Table B.5, for FalseExpNum, we can
see among all the linear regressions, when fitting with both ReadsAlignedPercentage and
ZeroMismatchPercentage, the adjusted R2 is generally larger than others. In contrast, for
FalseFcNum (Table B.6), we found that when fitting with ZeroMismatchPercentage, the
adjusted R2 is larger.
127















Overall, combined with Tables B.5 and B.6, Figures B.7 and B.8 show the key findings
of our study. FalseExpNum shows linear correlation with ReadsAlignedPercentage and
ZeroMismatchPercentage, and FalseFcNum shows linear correlation with ZeroMismatch-
Percentage. Since FalseExpNum and FalseFcNum are the metrics of gene expression es-
timation, and ReadsAlignedPercentage and ZeroMismatchPercentage are metrics of align-
ment, the linear correlation implies that with the increase of ReadsAlignedPercentage and
ZeroMismatchPercentage, the performance of gene expression estimation will improve.
We believe our foremost hypothesis might help to explain this phenomenon: reads aligned
with zero mismatch have higher probability to be correctly mapped, and ReadsAlignedPer-
centage quantifies the portion of reads that have been mapped. Combining ReadsAligned-
Percentage and ZeroMismatchPercentage, we might assess the performance of alignment,
while the better the performance of alignment, the better gene expression estimates. Our
finding also suggests applying aligners which can produce higher ReadsAlignedPercentage
and ZeroMismatchPercentage when conducting gene expression estimates-related analysis,
such as DEG detection.
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0.2 0.9140 0.0000 0.7978 0.0007 0.8922 0.0001 0.9187 0.0001 0.9502 0.0000
0.3 0.9010 0.0001 0.8172 0.0005 0.8086 0.0006 0.9148 0.0001 0.9024 0.0001
0.4 0.8762 0.0001 0.8075 0.0006 0.7612 0.0013 0.8909 0.0002 0.8656 0.0003
0.5 0.8597 0.0002 0.8043 0.0006 0.7386 0.0018 0.8767 0.0003 0.8441 0.0005
0.6 0.8492 0.0003 0.8004 0.0007 0.7172 0.0024 0.8670 0.0004 0.8292 0.0007
0.7 0.8327 0.0004 0.7927 0.0008 0.6906 0.0034 0.8510 0.0005 0.8077 0.0010
0.8 0.8200 0.0005 0.7909 0.0008 0.6736 0.0041 0.8412 0.0006 0.7920 0.0013
0.9 0.8101 0.0006 0.7894 0.0008 0.6572 0.0049 0.8336 0.0007 0.7796 0.0015















Figure B.7: Correlation between predicted FalseExpNum (with ReadsAlignedPercentage
and ZeroMismatchPercentage) and true FalseExpNum.
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0.2 0.7897 0.0008 0.8361 0.0003 0.6997 0.0030 0.8520 0.0006 0.7682 0.0018
0.3 0.7378 0.0019 0.8365 0.0003 0.7172 0.0024 0.8300 0.0009 0.7349 0.0029
0.4 0.6859 0.0036 0.8338 0.0004 0.7086 0.0027 0.8128 0.0014 0.6980 0.0047
0.5 0.6756 0.0040 0.8389 0.0003 0.6945 0.0032 0.8160 0.0014 0.6827 0.0054
0.6 0.6664 0.0045 0.8281 0.0004 0.6933 0.0033 0.8034 0.0017 0.6770 0.0058
0.7 0.6708 0.0042 0.8383 0.0003 0.6872 0.0035 0.8147 0.0015 0.6752 0.0058
0.8 0.6524 0.0052 0.8489 0.0003 0.6643 0.0046 0.8243 0.0013 0.6496 0.0072
0.9 0.6600 0.0048 0.8501 0.0003 0.6772 0.0040 0.8261 0.0013 0.6625 0.0065















Figure B.8: Correlation between FalseFcNum and ZeroMismatchPercentage.
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B.5 Conclusions
We analyzed the impact of RNA-seq aligners on gene expression estimation by constructing
RNA-seq data analysis pipelines with nine different aligners and one quantification tool,
HTSeq. Using simulated RNA-seq data, we have the true gene expression and true gene
fold change between samples.
We profiled the alignment performance with (1) the percentage of reads aligned (Read-
sAlignedPercentage), (2) the percentage of reads aligned with zero mismatch (ZeroMis-
matchPercentage), and the percentage of reads aligned with at most one mismatch (Ze-
roOneMismatchPercentage). We observed that for most aligners, the ReadsAlignedPer-
centage can be over 90%, and the reads aligned with zero or one mismatch can account for
over 80% of aligned reads.
We evaluated the gene expression estimation with three metrics: (1) the accuracy of
gene detection, (2) the number of genes falsely quantified (FalseExpNum), and (3) the
number of genes with falsely estimated fold change (FalseFcNum). We found that for most
pipelines, the accuracy of gene detection shows few discrepancies suggesting gene detec-
tion accuracy might not be a suitable metric for gene expression estimation. In contrast, for
FalseExpNum and FalseFcNum, the discrepancy among pipelines is more significant. In
addition, we observed linear correlation between FalseExpNum and FalseFcNum, suggest-
ing both FalseExpNum and FalseFcNum might be equally applied as the metric of gene
expression estimation. However, FalseExpNum is generally larger than FalseFcNum, im-
plying that the fold change of some genes will not be affected even though they are falsely
quantified.
We applied linear regression to model the relationship between the alignment pro-
file (ReadsAlignedPercentage, ZeroMismatchPercentage and ZeroOneMismatchPercent-
age) and the evaluation of gene expression (FalseExpNum and FalseFcNum). We observed
that FalseExpNum shows linear correlation with ReadsAlignedPercentage and ZeroMis-
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matchPercentage, and FalseFcNum shows linear correlation with ZeroMismatchPercent-
age. An explanation might be: (1) the reads aligned with zero mismatch are more likely to
be correctly mapped, which contributes more to accurate quantification; (2) the percentage
of reads aligned represents the amount of reads that might be correctly mapped. Therefore,
ZeroMismatchPercentage and ReadsAlignedPercentage might be combined as indicators
of the performance of gene expression estimates. We plan to verify this by applying our
method to real data in a future study. Since ZeroMismatchPercentage and ReadsAligned-
Percentage can be calculated without knowing the true alignment, indicating we can calcu-
late these two metrics for real data. Once got the above two alignment metrics, we might
assess the performance of gene expression estimation.
Overall, based on the results of our experiment, when conducting gene expression esti-
mation, we suggest applying aligners that produce higher ReadsAlignedPercentage and Ze-
roMismatchPercentage. Using this criterion, STAR, PASSION and GSNAP spliced align-
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